hg_67002.1

Basic information about the TSS

---

TSS ID: hg_67002.1 Species: human Chr: chr6		Start: 31636318 End: 31636352 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000492691.5 Distance: -72 GeneID: 7916 HGNC/MGI_ID: HGNC:13918 UniProt_ID:

Gene_name: proline rich coiled-coil 2A Gene_symbol: PRRC2A Gene_synonyms: D6S51E G2 Gene_source: HGNC:13918

TATA-Box annotation

---

Distance to TSS:	2548
Nearest PromoterID:	NR_106890
Entrez ID:	102466745
Nearest Unigene:
Nearest Refseq:	NR_106890
Nearest Ensembl:	ENSG00000274494
Gene Name:	proline rich coiled-coil 2A
Gene Alias:	hsa-mir-6832
Gene Description:	microRNA 6832
Gene Type:	ncRNA
CpG%:	0.015
GC%:	0.58209
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PRRC2A p2@PRRC2A p3@PRRC2A p5@PRRC2A p7@PRRC2A p8@PRRC2A p9@PRRC2A p10@PRRC2A
Sample		p1@PRRC2A	p2@PRRC2A	p3@PRRC2A	p5@PRRC2A	p7@PRRC2A	p8@PRRC2A	p9@PRRC2A	p10@PRRC2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	201.23	30.19	7.01	0.00	1.75	1.17	2.34	5.26
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	197.46	30.35	6.07	0.00	1.62	1.21	1.82	4.25
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	206.60	25.27	5.40	0.19	2.51	0.39	2.12	5.98
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	166.95	20.38	5.82	0.00	0.83	0.42	2.08	3.74
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	174.80	22.72	4.05	0.22	2.02	0.45	1.12	4.95
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	180.63	23.45	4.65	0.39	1.74	0.19	1.55	2.91
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	199.80	34.43	8.06	0.44	2.18	0.44	1.74	5.66
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	215.82	32.70	7.75	0.24	2.42	0.73	1.21	3.39
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	238.29	30.35	8.12	0.00	1.28	0.64	2.56	6.20
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	273.00	31.88	8.69	0.00	1.74	0.58	1.74	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	260.73	28.30	6.06	0.00	2.02	0.81	1.21	6.06
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	271.17	30.49	11.79	0.41	1.22	2.03	0.81	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	40.14	19.83	2.58	0.00	0.16	0.16	0.32	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	45.41	21.35	4.51	0.00	0.00	0.45	0.00	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	32.71	25.03	3.29	0.44	0.22	0.44	0.44	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	31.18	17.60	3.27	0.00	0.25	0.25	0.50	3.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	28.83	16.82	3.06	0.22	0.87	0.22	0.44	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.00	16.03	1.69	0.00	0.00	0.42	1.27	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	26.66	17.06	3.20	0.53	0.00	0.00	0.00	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.50	19.56	3.76	0.15	0.00	0.45	0.30	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	36.75	21.65	3.34	0.27	0.00	0.40	0.53	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	35.39	23.30	2.76	0.00	0.17	0.35	0.35	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.77	21.46	4.39	0.00	0.26	0.52	0.13	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	32.52	18.69	5.10	0.00	0.00	1.21	0.49	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	27.60	16.77	3.87	0.26	0.00	0.26	0.52	3.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	29.12	15.51	1.90	0.00	0.32	0.00	0.95	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.37	15.93	1.65	0.00	1.65	0.55	1.10	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	43.61	30.18	3.06	0.24	0.47	0.24	0.24	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.79	21.32	3.39	0.16	0.32	0.00	0.00	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.85	15.20	1.99	0.18	0.18	0.36	0.54	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	32.24	21.77	3.56	0.00	0.63	0.21	1.05	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	27.55	15.44	2.34	0.00	0.59	0.59	0.20	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	27.64	17.52	2.95	0.00	0.00	0.42	1.06	5.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	30.02	18.14	2.80	0.16	0.66	0.16	0.49	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	28.42	16.46	3.18	0.37	0.19	0.19	0.37	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	33.92	22.80	2.30	0.00	0.38	0.38	0.00	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	24.93	19.21	5.93	0.00	0.20	0.41	0.41	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	32.44	18.94	3.63	0.00	0.00	0.00	0.20	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	28.90	20.53	4.32	0.00	0.81	0.81	0.54	3.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.69	17.52	3.84	0.00	0.72	0.24	0.48	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	21.64	16.94	2.59	0.00	0.00	0.24	0.00	4.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	24.16	16.40	2.49	0.00	0.29	0.59	0.29	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	29.95	17.08	2.95	0.42	0.00	0.00	1.05	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	31.82	20.98	3.67	0.00	0.00	0.17	0.17	3.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.32	20.68	4.02	0.00	0.00	0.20	0.20	2.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	32.11	15.82	2.79	0.00	0.00	0.23	0.47	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	29.51	17.75	3.60	0.00	0.24	0.72	0.24	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	23.25	16.09	2.68	0.00	0.00	0.60	0.00	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.29	13.17	3.59	0.00	0.24	0.00	0.48	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.24	15.16	2.83	0.20	0.20	0.40	0.20	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.36	14.14	2.05	0.20	0.41	0.20	0.20	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	30.24	12.23	3.11	0.22	0.00	0.00	0.00	3.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	0.00	0.00	0.00	13.99	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	20.94	8.16	1.77	0.00	0.00	0.00	0.00	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.87	7.95	1.33	0.00	0.00	0.00	0.00	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	23.49	21.81	3.36	0.00	0.00	0.84	0.84	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	22.96	12.86	1.38	0.00	0.00	0.00	0.00	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	21.07	10.37	2.59	0.32	0.00	0.32	0.00	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.52	9.96	1.93	0.00	0.32	0.32	0.32	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.80	12.26	1.89	0.31	0.31	0.94	0.63	4.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	15.51	11.99	1.41	0.00	0.00	0.00	0.71	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	22.99	10.09	1.12	0.00	0.00	0.00	0.56	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	25.48	27.07	3.18	0.80	0.00	0.00	0.00	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	18.01	7.81	1.36	0.68	0.00	0.00	0.00	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.50	13.32	1.95	0.65	0.65	0.65	0.00	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	19.52	13.49	1.42	0.35	0.71	0.00	0.00	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	0.00	0.00	0.00	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	39.49	0.00	0.00	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.25	7.80	0.98	0.00	0.49	0.00	0.98	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.76	11.41	1.49	0.00	0.50	0.00	0.00	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	24.86	14.54	2.81	0.47	0.94	0.47	0.47	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	12.92	0.33	0.66	0.00	0.00	0.66	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	18.87	10.83	1.86	0.31	0.00	0.62	0.31	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	28.13	15.90	2.14	0.00	0.31	0.00	0.61	1.83
Adipocyte - breast, donor1	11376-118A8	23.60	7.29	4.75	0.16	0.48	0.16	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	29.20	9.30	5.78	0.00	0.48	0.32	0.16	0.64
Adipocyte - omental, donor1	11473-119C6	28.12	9.92	4.07	0.25	0.13	0.64	0.38	0.00
Adipocyte - omental, donor2	11474-119C7	23.92	14.20	7.47	0.00	0.75	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	18.09	10.38	6.36	0.33	1.00	1.34	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	17.23	8.93	3.83	0.00	0.00	0.00	0.00	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	5.50	2.20	0.00	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	25.74	14.45	3.61	0.00	0.90	0.00	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	42.05	14.25	7.99	0.17	0.35	0.35	0.87	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	80.18	23.27	12.71	0.78	0.78	0.39	0.78	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	42.47	18.27	5.66	0.26	0.00	0.00	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	42.37	14.22	5.02	0.00	0.28	0.00	0.28	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	49.96	21.75	8.82	0.59	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	70.06	23.81	10.22	0.48	0.72	0.72	0.08	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	47.12	18.72	5.16	0.00	0.00	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	47.45	13.33	8.00	0.53	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	35.06	15.02	6.68	0.00	1.67	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	23.71	3.74	5.82	0.00	0.83	0.42	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	30.14	12.56	5.27	0.25	0.25	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	28.14	9.49	5.89	0.00	0.33	0.00	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	32.88	7.31	6.09	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	100.77	37.35	7.29	0.00	0.22	0.22	0.22	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	96.10	48.05	8.96	0.00	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	43.13	21.56	3.59	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	63.69	30.40	5.94	0.18	0.36	0.00	0.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	63.59	25.10	10.04	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	73.14	31.43	9.86	0.00	0.41	0.41	0.21	0.62
Anulus Pulposus Cell, donor1	11248-116E6	27.92	13.04	5.15	0.23	0.34	0.11	0.23	0.11
Anulus Pulposus Cell, donor2	11463-119B5	38.21	21.06	5.88	0.24	0.00	0.00	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.22	13.03	5.39	0.00	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	28.65	9.12	6.51	0.00	0.43	0.43	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	2.14	2.14	0.00	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	11.66	5.08	0.00	1.20	0.30	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	13.91	7.59	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.18	1.98	1.98	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.34	10.40	5.20	0.00	0.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	27.18	7.28	6.80	0.49	0.97	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	5.34	4.75	0.00	0.00	0.00	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.23	8.29	4.90	0.00	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	20.32	8.71	5.08	0.00	0.00	0.73	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	11.28	2.51	0.00	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	19.60	6.10	3.13	0.16	0.00	0.00	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	6.82	5.46	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	13.42	3.17	2.56	0.30	0.15	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	34.29	8.04	8.04	0.00	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	26.83	8.69	4.35	0.00	0.00	0.19	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.64	6.15	4.54	0.00	0.27	0.27	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	10.73	3.90	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	21.89	9.95	4.98	0.00	0.33	0.17	0.17	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	4.80	1.20	0.00	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	14.16	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	26.76	12.01	8.23	0.00	0.00	0.17	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	0.00	0.00	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	10.19	7.77	0.49	0.97	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.28	8.73	7.21	0.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	4.85	4.85	0.00	1.21	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	20.52	9.69	7.41	0.00	0.00	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	22.66	8.55	3.21	0.00	0.00	0.64	0.43	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	11.87	3.61	3.10	0.00	0.26	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	26.28	10.79	5.63	0.00	0.47	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	20.90	7.07	5.79	0.00	0.32	0.00	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	4.28	0.00	0.71	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	25.74	8.19	2.92	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	25.29	7.23	5.12	0.00	0.00	0.30	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	7.13	3.56	0.00	1.19	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.94	10.68	6.10	0.00	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	20.38	8.40	4.84	0.00	0.76	0.00	0.51	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	16.52	5.08	3.81	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.71	9.49	4.75	0.00	0.00	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	19.26	8.89	3.18	0.21	0.00	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	7.25	2.03	1.74	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	21.73	14.17	4.72	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.43	8.82	5.76	0.00	0.00	0.00	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	4.63	0.00	2.32	0.00	2.32	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	40.14	10.56	4.23	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.30	10.72	4.07	0.00	0.21	0.00	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	4.81	1.20	0.00	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	26.24	11.66	2.19	0.73	0.00	0.73	2.19	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	27.13	8.74	3.91	0.00	0.46	0.00	0.69	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	5.10	0.00	0.00	0.00	0.00	2.55	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.92	2.29	1.02	0.00	0.00	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	28.49	11.35	6.61	0.00	0.21	0.00	0.41	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	17.44	4.59	3.06	0.00	0.31	0.00	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	25.81	12.43	8.13	0.00	0.00	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	24.83	7.76	5.32	0.00	0.00	0.22	0.00	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	1.53	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.25	6.09	3.32	0.00	0.55	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	27.01	9.27	5.03	0.00	0.26	0.26	0.79	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.72	6.91	3.63	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	111.89	71.72	15.11	0.49	0.25	0.12	0.12	0.37
Astrocyte - cerebellum, donor2	11580-120F5	109.03	64.36	18.31	0.17	0.51	0.17	0.34	1.20
Astrocyte - cerebellum, donor3	11661-122F5	105.08	46.98	10.49	0.21	0.84	0.63	0.84	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	63.79	31.72	6.62	0.70	0.35	0.00	0.00	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	91.24	42.71	6.63	0.00	1.13	0.16	1.62	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	105.31	41.76	7.46	0.15	0.15	0.45	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	138.20	40.48	23.40	0.23	0.69	0.57	0.92	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	154.60	38.84	22.30	0.25	0.75	0.50	0.25	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	130.18	36.41	17.87	0.00	0.23	0.91	0.57	0.57
Basophils, donor1	12241-129G9	32.17	13.08	10.46	0.00	0.00	0.00	0.26	0.00
Basophils, donor2	12242-129H1	40.05	14.43	9.74	1.44	0.00	0.36	0.00	0.00
Basophils, donor3	12243-129H2	56.59	15.14	16.90	0.73	0.15	0.15	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	70.07	21.13	4.96	0.00	0.22	0.43	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	111.55	48.46	8.69	0.00	1.37	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	47.70	21.34	4.39	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	77.98	32.23	4.78	0.00	0.83	0.62	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	62.41	32.24	7.14	0.23	1.15	0.92	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	50.38	17.09	6.30	0.18	0.18	0.00	0.36	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	131.91	44.11	22.05	1.24	0.10	0.31	0.21	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	104.11	41.46	16.30	0.70	0.23	0.00	0.00	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	56.28	33.90	8.63	2.88	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	31.03	20.68	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	38.89	10.71	13.53	0.56	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	48.81	16.33	22.46	0.19	0.74	0.37	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	52.03	13.83	17.34	0.00	0.66	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	33.12	6.79	14.15	0.28	0.57	0.00	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	34.50	8.72	12.89	0.38	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	43.39	11.83	22.68	0.33	0.66	0.66	0.00	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	46.26	10.84	10.26	0.14	0.43	0.00	0.87	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	38.32	11.47	5.13	0.00	0.00	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	48.56	9.24	11.84	0.00	0.24	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	36.99	9.37	5.69	0.17	0.33	0.33	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	25.95	7.18	4.69	0.00	0.00	0.00	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	41.40	7.44	6.20	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	27.61	5.87	4.70	0.00	0.00	0.20	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	27.78	6.77	3.74	0.00	0.00	0.36	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	23.50	6.53	3.92	0.65	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	26.22	4.68	4.45	0.00	0.23	0.47	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	30.10	10.56	3.70	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	36.61	7.77	4.44	0.00	2.22	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	31.98	9.97	5.50	0.00	0.45	0.15	0.30	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	32.33	7.38	4.39	0.00	0.20	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	28.94	4.58	4.37	0.62	0.00	0.21	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	26.77	6.63	3.66	0.00	0.46	0.23	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	24.66	7.69	4.30	0.23	0.23	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	23.57	5.67	5.24	0.00	0.87	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	32.28	11.57	5.38	0.27	0.27	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	36.99	10.99	7.85	0.17	0.17	0.00	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	49.24	11.36	8.84	0.00	0.00	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	30.68	8.27	5.14	0.00	0.55	0.00	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.70	12.68	2.47	0.00	0.00	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	37.73	7.90	5.26	0.00	0.00	0.44	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	30.17	8.54	4.36	0.35	0.35	0.52	0.17	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.82	8.55	4.46	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	23.49	9.27	4.10	0.43	0.22	0.00	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	46.68	6.55	4.91	0.00	0.00	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	25.03	4.87	4.40	0.23	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	20.18	3.48	1.86	0.46	0.00	0.23	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	19.83	4.58	7.85	0.00	0.00	0.00	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	21.02	3.00	6.01	0.23	0.00	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	15.16	2.60	7.15	0.22	0.00	0.22	0.00	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	34.41	9.97	16.51	0.47	0.47	0.16	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	32.13	5.76	11.88	0.17	0.17	0.17	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	62.88	14.49	22.52	1.34	0.22	0.22	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	18.63	2.30	8.93	0.00	0.00	0.26	0.51	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	22.62	2.85	6.81	0.44	0.44	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	18.74	1.26	5.90	0.84	0.21	0.00	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	6.10	20.32	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.07	17.63	12.88	2.03	0.68	0.00	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	54.89	9.32	19.68	2.07	2.07	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	36.25	12.26	13.33	2.13	0.53	0.53	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	40.21	11.26	18.23	2.68	0.54	0.00	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	35.80	11.23	15.44	2.11	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	43.14	9.41	11.77	2.35	0.00	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	35.59	10.55	10.55	6.59	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	93.70	38.63	25.48	0.00	1.64	0.00	1.64	1.64
CD19+ B Cells, donor2	11624-122B4	67.46	26.12	23.21	0.00	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	83.30	32.81	17.67	0.50	0.50	0.00	0.50	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	63.84	19.39	16.16	0.40	0.00	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	51.93	8.79	15.58	0.00	0.00	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	51.21	26.11	7.03	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	66.86	27.53	7.87	0.56	0.56	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	60.87	33.82	11.27	0.75	0.75	0.00	0.00	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	64.04	33.15	8.34	1.58	0.00	0.23	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	89.26	40.70	24.64	1.43	0.00	0.00	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	66.75	34.29	20.21	0.61	1.84	0.00	0.61	3.06
CD4+ T Cells, donor3	11382-118B5	70.15	33.85	16.47	0.30	0.00	0.00	0.00	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	37.77	15.82	15.82	0.26	0.26	0.00	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	38.18	16.40	13.25	2.47	0.67	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	38.23	11.79	14.66	1.44	0.00	0.00	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	43.62	14.22	12.80	0.95	0.00	0.00	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	47.06	11.94	10.53	1.40	0.00	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	29.67	13.18	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	41.19	20.95	12.28	1.01	0.43	0.58	0.72	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	44.06	20.34	13.90	0.17	1.19	0.17	0.68	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.95	16.28	10.16	0.16	0.32	0.16	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	33.17	13.00	8.52	3.14	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	24.46	11.53	6.64	1.75	0.35	0.00	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	45.76	13.20	15.40	0.44	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	53.97	17.71	12.65	0.42	0.84	0.00	0.42	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	44.67	14.13	13.51	0.62	0.00	0.21	0.42	1.45
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	33.08	15.37	10.02	0.33	0.00	0.00	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	60.37	15.77	23.93	3.26	0.54	0.00	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	60.56	22.51	23.05	2.14	0.54	0.54	0.00	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	71.73	19.73	25.11	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	62.67	30.60	13.54	1.48	1.11	0.19	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	45.92	21.23	13.86	0.87	0.43	0.00	0.65	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	51.07	23.12	16.39	1.47	0.21	0.42	0.84	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	43.99	15.17	11.12	0.51	0.00	0.00	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	33.36	12.56	8.67	1.73	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	62.32	24.84	20.48	3.05	1.74	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	51.47	19.79	16.33	4.45	1.48	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	42.47	11.08	14.77	0.92	0.92	0.00	1.85	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	30.71	15.35	19.54	5.58	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	69.51	25.20	31.29	1.94	0.00	0.55	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	67.97	36.07	32.88	3.19	0.49	0.25	0.49	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	50.82	12.32	29.26	4.62	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	56.94	23.99	24.35	2.15	0.00	0.00	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	40.16	24.93	19.39	5.54	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	71.04	25.54	18.99	1.31	0.33	0.00	0.33	0.98
CD8+ T Cells, donor2	11307-117C2	72.46	33.41	19.90	0.00	0.75	0.00	0.38	1.88
CD8+ T Cells, donor3	11383-118B6	89.38	31.56	22.98	0.50	1.26	0.25	0.25	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	41.75	24.09	5.05	0.00	0.00	0.00	0.46	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	38.34	24.68	4.79	0.00	0.72	0.00	0.72	1.44
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.82	17.78	3.56	0.00	0.27	0.00	1.09	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	47.43	25.22	3.90	0.00	1.20	0.00	0.30	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	45.12	23.04	6.00	0.48	0.24	0.00	0.24	1.20
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	44.57	26.38	4.55	0.00	0.68	0.00	0.45	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	49.76	31.72	2.82	0.22	0.22	0.00	1.09	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	40.80	21.85	5.26	0.00	0.26	0.53	0.79	2.37
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	48.54	27.91	3.05	0.23	0.23	0.23	0.94	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	44.38	25.06	2.72	0.00	0.30	0.00	0.60	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	33.99	27.89	3.49	0.29	0.29	0.00	0.29	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	52.49	28.77	3.46	0.00	0.27	0.00	0.53	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	48.15	23.64	2.19	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	50.55	30.51	2.28	0.00	0.91	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	58.18	31.33	5.22	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	57.99	20.17	6.12	0.36	0.72	0.00	0.72	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	48.34	19.85	6.04	0.29	0.29	0.58	0.00	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	39.36	24.28	4.71	0.00	0.00	0.24	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	75.11	32.64	2.85	0.00	0.32	0.32	1.27	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	46.44	32.60	1.54	0.31	0.92	0.00	0.31	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	59.63	27.89	3.53	0.00	0.32	0.00	0.96	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	50.87	20.27	3.82	0.00	0.00	0.00	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	55.96	20.10	2.36	0.00	0.39	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	35.55	18.15	2.27	0.00	0.00	0.00	0.00	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	68.25	22.48	1.61	0.00	0.80	0.00	0.00	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	64.35	30.77	6.29	0.70	0.00	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	108.19	37.06	3.01	0.00	2.00	0.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	42.04	12.79	5.48	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	43.97	13.34	4.45	0.00	0.00	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	41.25	18.21	4.84	0.11	0.00	0.00	0.11	0.21
Chondrocyte - de diff, donor1	11261-116G1	39.17	17.33	5.89	0.35	0.69	0.00	0.00	1.04
Chondrocyte - de diff, donor2	11338-117F6	42.65	14.57	4.26	0.36	0.36	0.00	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	32.31	16.50	2.84	0.00	0.68	0.34	0.80	0.23
Chondrocyte - re diff, donor2	11339-117F7	77.89	28.65	11.64	1.79	1.79	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	57.83	21.03	9.30	0.00	0.00	0.81	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	66.22	30.76	10.44	0.46	0.57	0.34	0.46	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	54.94	26.08	6.63	0.00	0.00	0.00	1.07	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	71.68	30.71	7.35	0.00	0.18	0.27	0.18	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	109.49	71.34	35.30	2.29	1.28	1.19	0.73	0.92
Corneal Epithelial Cells, donor1	11526-119I5	97.49	36.23	9.88	0.00	0.44	0.66	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	51.19	21.61	2.28	0.00	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	75.16	25.82	6.14	0.00	0.26	0.26	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	28.73	11.06	8.25	0.17	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.13	13.25	6.62	0.32	0.00	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	10.35	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	26.13	10.58	5.83	0.11	0.22	0.11	0.32	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	50.90	35.87	8.88	4.44	0.34	0.00	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	45.05	30.03	8.49	1.31	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	44.04	38.23	8.23	1.45	0.48	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	73.04	40.36	6.34	0.17	0.50	0.00	0.17	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	62.79	20.54	7.04	0.00	0.00	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	98.13	38.18	7.92	0.28	0.28	0.57	0.00	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	73.13	31.45	4.72	0.39	0.00	0.79	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	71.26	32.00	3.20	0.00	0.87	0.58	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	92.70	40.23	6.35	0.00	0.47	0.47	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	102.38	41.20	8.77	0.00	0.70	0.53	0.70	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	44.77	15.07	4.43	0.00	0.22	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	59.94	22.52	6.39	0.00	0.00	0.30	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	55.25	26.78	8.18	0.85	0.28	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	55.56	27.93	4.46	0.89	0.30	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	54.15	15.10	4.69	0.52	0.00	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	49.34	24.25	7.23	0.00	0.28	0.57	0.57	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	72.42	35.61	3.60	0.40	0.00	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	52.94	24.11	4.19	0.00	0.00	0.52	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	87.72	38.52	10.06	0.25	0.37	0.62	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	82.56	44.97	7.39	0.00	0.22	0.22	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	113.21	48.73	8.06	0.00	0.24	0.00	0.24	0.37
Endothelial Cells - Vein, donor1	11267-116G7	103.51	38.68	13.65	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	106.17	38.42	6.99	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	75.05	31.09	5.97	0.16	0.31	0.63	0.63	0.16
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	165.03	28.05	59.41	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	99.87	21.40	67.77	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	72.32	26.63	6.11	0.00	0.24	0.00	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	45.76	22.88	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.18	13.55	3.28	0.82	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.03	4.38	2.52	0.22	0.22	0.33	0.00	1.64
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	23.40	11.16	3.25	0.00	0.65	0.76	0.33	3.79
Fibroblast - Aortic Adventitial, donor1	11245-116E3	45.24	16.74	4.61	0.00	0.73	0.36	0.36	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	59.50	18.83	8.46	0.14	0.27	0.27	0.00	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	42.19	11.29	5.91	0.00	0.32	0.53	0.74	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	66.14	29.51	9.22	0.00	0.53	0.26	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	66.44	28.90	6.98	0.00	0.66	0.33	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	43.55	18.15	5.44	0.00	0.00	0.00	0.00	0.91
Fibroblast - Cardiac, donor2	11345-117G4	65.94	18.95	9.85	1.52	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	58.20	20.03	4.42	0.00	1.10	0.32	0.32	0.16
Fibroblast - Cardiac, donor4	11452-119A3	55.77	32.43	8.49	0.00	0.61	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	42.01	22.84	6.47	0.00	0.38	0.38	0.63	0.25
Fibroblast - Cardiac, donor6	11460-119B2	45.78	22.89	4.70	0.00	0.00	0.15	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	80.53	37.25	8.98	0.40	0.13	0.00	0.67	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	55.22	24.59	3.88	0.00	0.00	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	74.70	45.41	7.32	0.00	0.00	1.46	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	197.89	95.48	12.69	0.00	0.23	0.92	0.69	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	37.82	19.67	4.75	0.34	0.17	0.00	0.68	0.17
Fibroblast - Dermal, donor1	11269-116G9	35.22	13.85	9.86	0.00	0.47	0.70	0.23	0.70
Fibroblast - Dermal, donor2	11346-117G5	75.47	27.36	5.19	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	37.23	20.31	5.80	0.00	0.48	0.12	0.24	1.09
Fibroblast - Dermal, donor4	11450-119A1	66.58	32.67	5.99	0.23	0.45	0.00	0.68	0.79
Fibroblast - Dermal, donor5	11454-119A5	72.05	40.82	7.68	0.00	0.17	0.00	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	81.37	43.69	9.10	0.00	0.49	0.00	0.32	0.32
Fibroblast - Gingival, donor1	11237-116D4	55.60	19.57	7.08	0.42	0.21	0.21	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.57	20.70	8.38	0.00	1.57	0.79	1.05	0.79
Fibroblast - Gingival, donor2	11318-117D4	72.48	28.20	6.46	0.00	0.13	0.00	0.00	0.66
Fibroblast - Gingival, donor3	11394-118C8	64.30	29.01	9.09	0.00	0.29	0.39	0.58	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	36.36	21.82	6.23	0.00	0.00	0.00	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	36.65	17.09	4.76	0.00	0.70	0.88	0.70	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	107.57	35.39	10.45	0.00	0.16	0.16	0.00	1.09
Fibroblast - Gingival, donor6 (control)	11922-125H5	67.07	26.10	4.73	0.14	0.68	0.41	0.54	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	104.10	34.58	9.53	0.00	1.41	2.82	1.76	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	60.55	21.06	3.51	0.00	0.73	0.15	0.58	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	60.13	22.23	4.09	0.14	0.14	0.55	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	83.37	37.52	5.81	0.00	0.66	0.66	0.66	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	44.32	19.66	5.87	0.15	0.44	1.17	0.59	0.73
Fibroblast - Lung, donor1	11270-116H1	63.89	35.34	8.16	0.00	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	49.24	58.19	1.49	0.00	1.49	1.49	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	52.34	28.28	5.70	0.00	0.00	0.63	0.21	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	173.27	77.47	21.66	0.00	0.00	0.00	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	65.74	29.37	4.20	0.00	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	69.97	27.71	8.96	0.00	0.00	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	187.56	66.17	24.76	0.00	0.00	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	79.88	43.94	11.98	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	89.34	11.91	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	57.03	24.63	7.37	0.00	0.19	0.19	0.00	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	110.58	53.39	8.34	0.00	1.06	0.15	0.91	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	101.89	36.41	11.63	0.00	0.61	0.00	0.31	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	62.97	23.66	8.01	0.00	0.00	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	46.44	18.63	4.86	0.00	0.54	0.27	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	45.00	19.25	5.68	0.00	0.46	0.81	0.46	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	30.84	10.72	2.76	0.11	0.22	0.11	0.22	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	163.57	53.24	12.80	0.20	0.41	0.41	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	106.24	46.77	14.03	0.00	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.75	18.98	6.33	0.00	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	122.84	45.64	9.72	0.00	0.79	0.20	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.48	13.50	4.97	0.36	0.18	0.00	0.36	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	52.03	17.54	6.31	0.39	0.20	0.00	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	72.51	28.88	8.42	0.00	0.00	0.00	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	52.36	19.97	9.72	0.76	0.43	0.22	0.43	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	64.03	28.09	9.87	0.00	0.25	0.00	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	41.35	15.42	8.53	0.00	0.00	0.16	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	105.47	44.91	8.42	0.80	0.40	0.20	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	50.43	19.59	7.13	0.10	0.50	0.10	0.20	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	95.51	46.54	14.21	0.30	0.60	0.00	0.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.59	14.00	7.21	0.33	0.08	0.25	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	47.52	17.44	15.56	0.34	0.34	0.17	0.34	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	71.93	30.87	10.18	0.33	0.66	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	58.27	24.82	8.52	0.43	0.53	0.53	0.32	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	74.39	28.17	5.74	0.00	0.51	0.00	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.05	10.51	1.88	0.00	0.63	0.16	0.78	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	56.65	26.15	13.07	0.00	0.00	0.87	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	32.76	6.41	4.16	0.35	0.00	0.00	0.35	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	61.68	18.22	7.29	0.78	0.00	0.52	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	63.62	21.72	5.62	0.26	0.51	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	72.73	28.33	3.83	0.00	1.53	0.77	3.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	66.36	17.87	3.83	0.00	3.19	0.64	1.28	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	102.12	37.08	5.71	0.29	1.71	1.71	1.43	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	127.95	38.88	7.45	0.28	3.03	2.21	1.93	5.24
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	87.68	42.70	6.16	0.23	2.28	1.37	2.28	2.74
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	109.17	40.42	8.72	0.40	1.39	2.18	1.59	4.36
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	98.07	37.54	7.14	0.79	3.97	1.59	0.79	3.70
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	86.10	42.40	6.20	0.98	2.28	1.96	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	73.41	26.09	4.86	0.00	1.33	1.77	1.33	3.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	154.18	62.61	13.00	0.00	0.99	0.57	1.27	1.27
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	134.96	56.65	10.59	0.12	0.49	0.99	0.62	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	121.15	48.35	11.01	0.54	0.54	0.27	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	102.71	41.63	6.57	0.50	0.62	0.99	0.25	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	112.54	43.47	9.14	0.14	1.38	0.69	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	88.03	29.68	4.27	0.41	0.81	0.20	0.81	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	75.76	29.89	5.48	0.00	0.46	1.37	0.68	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	76.23	31.76	7.10	0.00	0.75	0.75	0.25	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	87.65	34.75	6.56	0.00	0.66	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	81.55	34.28	3.55	0.00	0.89	1.77	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	98.40	43.55	9.70	0.48	0.79	1.43	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	94.28	41.11	5.59	0.22	0.22	0.00	0.45	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	79.44	37.71	6.86	0.20	1.61	1.01	1.21	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	85.67	40.04	5.94	0.00	0.51	0.68	0.51	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	85.48	39.28	6.92	0.44	1.06	0.44	0.44	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	124.97	70.34	9.68	0.73	2.08	2.29	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	128.94	58.92	8.54	1.02	1.02	1.37	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	90.74	47.47	7.52	0.11	0.44	1.33	0.44	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	69.64	36.69	7.90	0.25	0.92	0.75	0.08	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	82.69	28.99	4.49	0.00	0.61	0.61	0.41	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	72.83	34.04	5.78	0.21	1.24	0.62	0.41	1.65
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	100.19	44.62	6.69	0.12	0.58	0.58	0.23	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	72.04	33.35	5.50	0.00	0.17	0.83	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	72.52	31.08	5.07	0.00	0.22	1.10	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	94.95	43.29	6.27	0.12	1.23	0.37	0.61	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	90.29	38.25	6.16	0.00	0.49	0.65	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	82.42	38.81	3.85	0.00	1.28	0.00	0.96	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	74.10	37.81	5.69	0.09	0.85	0.47	0.38	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	75.77	30.84	4.11	0.32	1.42	0.47	0.32	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	62.34	30.41	5.47	0.00	1.22	1.52	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	78.09	39.31	5.85	0.00	0.63	0.73	0.10	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	63.23	30.52	3.95	0.22	0.88	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	76.59	35.07	4.49	0.00	0.56	1.12	0.84	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	69.72	34.26	4.07	0.09	0.46	0.28	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	47.87	21.93	2.41	0.27	0.53	0.53	0.27	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	61.97	25.40	4.74	0.00	0.77	0.15	0.00	2.60
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	65.29	27.20	3.89	0.13	0.13	0.78	0.13	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	52.59	26.29	2.71	0.54	0.54	0.54	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	59.91	35.03	5.16	0.00	0.37	0.74	1.66	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	64.70	33.77	4.82	0.22	1.32	1.10	0.22	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	115.04	62.48	10.91	0.99	0.00	3.97	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	58.96	32.71	3.96	0.00	0.13	0.40	0.53	1.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	60.33	30.06	2.62	0.20	0.40	0.40	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	129.62	79.04	18.55	1.02	0.76	1.78	1.02	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	167.81	80.62	16.72	1.00	1.19	1.59	0.60	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	178.88	69.49	15.87	0.00	0.92	2.16	0.00	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	188.63	86.74	13.71	0.20	0.61	1.02	0.61	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	51.01	19.40	4.38	0.31	0.63	0.00	0.63	1.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	50.86	15.82	3.96	0.28	0.00	0.00	0.00	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	95.47	41.05	8.30	0.00	0.00	0.92	0.00	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	133.64	39.60	9.90	0.00	0.00	2.47	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	89.35	30.17	8.90	0.00	1.55	0.77	0.77	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	78.62	25.67	4.81	0.00	0.00	0.00	0.00	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	126.93	36.52	6.96	0.00	0.00	0.00	1.74	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	75.51	20.83	4.23	0.00	0.65	0.98	1.63	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	80.71	30.06	6.18	0.00	1.65	1.65	1.65	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	59.98	29.99	3.33	0.00	0.00	0.00	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	65.72	28.52	4.75	0.28	0.56	0.84	0.28	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	65.70	26.80	5.23	2.29	0.33	0.33	0.33	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	108.21	34.39	11.74	0.84	0.84	0.84	1.68	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	72.84	27.67	7.32	0.00	0.32	0.32	1.59	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	80.84	25.81	7.47	0.34	1.02	1.02	0.68	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	62.64	20.88	8.35	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	83.04	28.06	9.74	0.57	0.57	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	70.15	25.16	5.92	0.59	1.78	0.89	0.30	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	59.30	25.41	5.08	0.00	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	71.66	25.68	4.14	0.00	0.83	0.83	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	80.78	28.08	7.82	0.69	0.46	1.15	1.15	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	15.81	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	56.51	17.30	5.38	0.00	0.77	0.00	0.00	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	50.20	15.97	3.26	0.33	1.96	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	24.75	8.69	3.34	0.67	0.00	0.67	0.00	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	77.05	29.28	6.55	0.00	3.85	2.31	2.70	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	83.53	29.44	8.90	1.03	0.34	1.03	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	99.39	34.79	4.97	4.97	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	75.50	27.84	7.55	1.42	0.00	1.89	0.47	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	61.56	21.12	6.03	0.00	0.00	0.60	0.60	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	79.35	25.94	9.66	0.00	1.02	0.00	1.02	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	78.17	21.14	6.78	0.40	0.40	2.39	0.00	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	65.12	24.17	4.93	0.49	2.47	0.99	0.00	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	73.19	20.07	9.44	0.00	1.18	1.18	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	52.51	24.50	4.08	0.58	0.00	2.92	1.75	3.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	94.36	24.58	11.41	0.88	1.32	0.44	0.88	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	61.03	14.41	4.24	0.85	0.85	0.85	0.85	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	56.11	20.89	7.16	0.00	0.60	0.00	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	55.32	19.90	5.82	0.00	0.97	0.97	1.46	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	50.22	12.55	7.99	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	59.46	21.21	5.82	0.00	0.83	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	75.34	29.24	11.24	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	33.30	8.56	7.29	0.00	0.63	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.04	3.34	5.43	0.42	0.00	0.00	0.84	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	62.31	29.24	5.92	0.23	0.23	0.12	0.58	1.62
Hep-2 cells mock treated, biol_rep2	11899-125E9	69.72	27.51	4.73	0.00	0.84	0.17	0.68	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	60.97	27.30	3.19	0.00	0.91	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	62.85	28.20	5.03	0.11	0.98	0.22	0.55	0.98
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	75.22	25.14	4.73	0.00	0.21	0.00	0.43	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	64.58	25.62	4.74	0.00	0.22	0.65	0.22	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	46.20	19.30	1.62	0.00	0.12	0.25	0.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	42.72	15.78	1.20	0.00	0.00	0.00	0.00	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	42.29	17.30	3.20	0.00	0.00	0.64	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	80.03	36.38	7.83	0.00	0.00	0.56	2.24	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	98.24	37.65	9.52	0.00	0.87	0.43	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	15.86	0.00	0.00	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	108.99	38.45	11.99	0.00	0.00	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	73.38	23.97	3.63	0.00	0.00	2.18	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	40.21	18.18	4.02	0.17	0.17	0.17	0.00	0.35
Hepatocyte, donor1	11523-119I2	20.58	4.84	10.90	0.00	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	54.94	19.39	4.31	1.08	0.00	0.00	0.00	1.08
Hepatocyte, donor3	11684-122I1	36.20	7.98	5.52	0.00	1.23	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	95.94	45.69	9.79	0.00	1.31	0.00	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	68.51	26.74	8.21	0.00	1.05	0.52	0.17	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	46.79	20.58	5.35	0.14	0.27	0.27	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	219.69	89.15	22.29	0.00	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	166.88	53.40	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	189.58	135.42	0.00	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	166.13	56.76	13.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	182.69	55.06	10.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	47.47	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	222.97	69.20	20.50	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	169.12	73.13	32.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	212.79	82.84	14.62	0.00	0.00	1.62	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	148.39	58.36	3.33	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	225.10	58.09	7.26	3.63	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	201.17	95.29	3.97	0.00	0.00	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	156.32	64.30	8.87	0.00	0.00	0.00	3.33	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	199.05	36.67	20.95	0.00	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	176.36	73.69	14.49	0.63	0.00	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	170.13	78.88	7.73	0.00	1.55	0.00	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	265.52	85.92	14.21	0.00	0.65	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	267.25	107.87	16.10	0.00	0.00	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	71.69	23.90	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	268.91	89.64	17.11	0.00	0.00	0.00	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	186.40	80.60	11.33	0.42	0.84	0.84	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	143.72	14.37	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	220.21	73.14	12.86	0.80	0.80	2.41	3.21	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	157.88	70.17	9.23	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	75.40	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	149.64	51.45	6.61	0.00	1.42	0.47	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	146.02	49.88	3.63	0.91	0.00	0.00	4.53	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	14.74	29.48	0.00	0.00	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	201.23	59.19	7.53	0.00	1.08	0.00	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	189.30	69.88	8.89	0.00	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	65.72	16.43	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	230.84	82.90	11.48	0.64	1.28	0.00	1.91	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	162.22	72.91	18.23	0.00	0.00	0.00	1.82	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	223.50	77.12	8.57	0.00	1.43	1.43	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	185.83	46.46	6.64	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	159.27	58.03	10.19	0.31	0.62	0.31	2.16	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	247.60	66.73	26.34	0.00	0.00	1.76	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	163.44	84.86	15.72	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	232.96	74.41	11.82	0.00	2.78	0.00	0.70	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	298.77	201.39	37.62	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	188.04	48.63	12.97	0.00	0.00	0.00	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	245.88	119.45	20.05	0.00	1.74	3.49	3.49	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	233.98	137.24	22.50	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	275.28	170.74	10.45	0.00	3.48	0.00	6.97	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	299.76	150.42	19.20	0.00	4.27	1.07	4.27	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	241.07	112.22	11.08	0.00	0.00	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	170.98	71.24	11.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	188.69	80.08	11.97	0.00	2.76	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	287.41	139.16	27.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	291.81	167.63	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	235.79	120.54	16.92	0.00	2.11	0.00	2.11	2.11
Keratinocyte - epidermal, donor1	11272-116H3	65.69	23.75	5.88	0.33	0.16	0.57	0.16	0.08
Keratinocyte - epidermal, donor2	11349-117G8	72.03	32.21	8.20	0.00	0.00	0.59	1.17	1.17
Keratinocyte - epidermal, donor3	11421-118F8	63.99	30.38	3.69	0.09	0.47	0.19	0.09	0.57
Keratinocyte - oral, donor1	11251-116E9	75.26	36.33	11.24	0.00	0.45	0.23	0.79	0.45
Keratocytes, donor1	11527-119I6	191.51	93.52	9.28	1.03	0.69	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	80.85	30.47	2.34	0.00	1.17	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	51.77	36.75	4.74	0.20	0.00	0.40	0.59	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	87.92	46.16	13.19	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	58.25	18.34	2.16	0.00	1.08	0.00	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	60.32	37.94	6.80	0.23	0.12	0.00	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	58.43	22.40	10.70	0.20	0.20	0.10	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	52.65	20.63	5.10	0.36	0.00	0.36	0.36	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	26.79	13.67	2.23	0.28	0.84	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	43.13	18.89	4.72	0.00	0.16	0.16	0.47	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	37.10	11.29	1.08	0.00	0.00	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	40.66	16.39	3.15	0.00	0.00	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	40.97	17.68	2.91	0.00	0.43	0.11	0.65	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.47	15.18	2.87	0.00	0.00	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	38.93	15.93	4.80	0.00	0.25	0.00	0.25	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	42.08	17.31	4.79	0.28	0.14	0.00	0.28	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	39.16	14.24	2.37	0.00	1.19	0.00	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	35.09	13.18	3.10	0.00	0.39	0.19	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	37.21	14.44	5.55	0.00	0.19	0.00	0.19	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	47.04	15.68	3.14	0.00	0.35	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	35.30	11.93	3.58	0.00	0.00	0.00	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	39.69	15.25	3.30	0.14	0.27	0.14	0.27	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	38.19	15.40	2.77	0.31	0.31	0.00	0.31	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.38	14.65	0.62	0.00	0.62	0.00	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.32	21.78	4.76	0.18	0.37	0.00	1.10	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	30.94	14.15	2.30	0.00	0.00	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	34.56	15.52	3.81	0.29	0.29	0.00	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	43.56	16.43	4.98	0.25	0.50	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	31.04	8.24	1.45	0.00	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	36.89	12.93	1.62	0.54	0.00	0.27	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	41.63	18.17	5.15	0.00	0.30	0.15	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	40.44	9.85	2.07	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	36.43	14.03	3.35	0.00	0.42	0.21	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	44.21	20.45	3.76	0.15	0.30	0.30	0.45	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	39.21	13.07	2.06	0.00	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	33.68	12.61	2.26	0.00	0.38	0.00	0.00	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	43.26	18.24	5.73	0.11	0.32	0.21	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	43.13	9.69	2.42	0.00	0.00	0.48	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	27.46	12.57	3.31	0.00	0.33	0.00	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	42.62	22.42	3.72	0.12	0.50	0.00	0.50	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	53.68	17.03	3.33	0.00	0.00	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.92	7.91	1.48	0.00	0.00	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	40.70	15.26	5.22	0.00	0.41	0.14	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	43.42	15.76	1.93	0.32	0.00	0.00	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	37.74	12.78	3.65	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	38.63	16.52	3.64	0.00	0.42	0.28	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	38.40	13.16	2.13	0.00	0.00	0.00	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	30.06	8.24	2.42	0.48	0.00	0.00	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	45.13	19.76	4.67	0.00	0.31	0.00	0.47	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.45	13.25	3.22	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	39.85	17.97	4.25	0.00	0.33	0.00	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	34.61	12.95	3.30	0.24	0.47	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	60.89	25.37	4.70	0.00	0.50	0.25	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.45	11.27	2.82	0.26	0.00	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	42.37	22.08	4.77	0.00	0.30	0.00	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	11.33	2.27	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	67.51	31.45	14.58	0.00	0.00	0.00	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	66.80	26.72	11.88	0.00	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	54.16	24.12	12.69	0.85	0.00	0.00	1.69	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	64.00	25.32	13.36	0.70	0.00	0.70	0.00	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	60.71	23.35	14.94	0.93	0.93	0.00	0.00	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	40.71	15.46	9.27	2.58	0.00	0.00	2.06	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	58.28	34.49	13.08	1.19	0.00	0.00	1.19	5.95
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	45.01	24.88	11.08	0.23	0.45	0.23	0.45	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	30.83	16.58	9.89	0.58	0.58	0.00	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.02	21.61	12.15	0.00	0.00	0.45	0.45	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	79.53	34.14	17.75	0.95	0.54	0.41	0.54	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	58.54	27.22	7.70	1.03	1.03	0.51	0.51	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	51.52	27.17	9.53	0.00	0.00	0.00	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	42.64	14.66	6.00	0.00	0.00	1.33	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	54.50	27.00	6.11	1.53	2.04	0.00	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	54.96	26.68	14.41	0.27	0.80	0.00	0.27	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	66.89	27.96	11.53	0.38	0.76	0.57	1.13	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	48.47	23.32	10.43	1.84	0.00	0.61	1.84	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	97.85	65.23	13.86	1.63	0.82	0.82	0.82	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	55.60	31.44	9.79	0.42	0.00	0.42	0.83	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	43.72	22.98	8.13	0.56	0.84	0.28	0.84	3.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	62.85	38.12	18.55	1.03	1.03	0.00	1.03	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	54.58	22.93	10.45	0.29	1.16	0.58	1.45	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	34.08	13.15	7.47	0.30	0.60	1.20	0.60	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	47.03	28.77	10.51	0.00	0.55	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	87.31	43.48	15.91	0.71	0.35	0.35	2.12	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	52.74	24.34	13.28	0.74	0.37	0.37	0.74	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	54.11	29.93	11.51	0.00	1.15	1.15	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	64.09	35.31	17.65	0.38	0.38	1.15	1.15	1.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.29	23.78	5.10	1.13	0.57	0.00	2.26	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	53.33	27.90	17.23	0.82	0.00	0.00	0.82	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	72.30	36.60	16.72	0.90	0.00	1.81	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	58.17	20.83	14.36	0.00	0.00	0.72	0.00	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	70.96	44.07	11.20	0.00	0.00	0.00	0.00	2.99
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	69.49	41.62	15.98	0.74	0.74	0.00	2.23	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	50.83	18.95	8.18	0.43	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	68.50	45.38	13.70	0.86	0.00	1.71	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	72.63	36.98	14.33	1.33	1.00	0.33	1.00	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	60.93	27.75	11.46	1.21	0.00	0.60	1.21	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	81.05	31.99	12.09	0.00	0.00	0.71	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	72.52	29.56	15.47	0.34	0.69	0.00	1.03	3.44
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	75.14	32.74	13.96	1.61	1.61	0.54	1.07	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	73.40	38.38	14.14	1.35	0.00	1.35	0.67	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	78.90	41.86	12.59	0.74	1.11	0.37	1.48	4.82
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	51.17	34.89	1.16	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	49.71	26.44	13.75	0.00	0.00	1.06	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	103.64	42.82	16.41	0.00	0.40	0.40	2.00	3.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	62.51	23.26	11.63	0.00	0.00	0.73	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	76.65	39.86	24.53	1.53	0.00	0.00	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	82.87	39.46	24.66	0.49	0.00	0.00	0.49	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.99	17.88	10.35	2.82	0.94	0.00	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	75.42	37.21	19.61	0.00	0.50	0.00	0.00	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	80.66	29.74	15.77	0.45	0.90	0.00	1.35	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	56.80	24.10	12.05	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	84.17	47.65	19.15	1.34	1.78	0.00	0.89	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	100.88	32.46	13.29	0.00	1.96	0.78	0.78	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	48.16	25.73	6.60	0.00	0.66	1.32	0.00	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	77.32	35.29	19.72	0.52	1.04	0.52	0.52	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	88.39	39.38	10.06	1.75	0.88	0.88	0.44	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	50.88	19.01	14.54	1.12	1.12	0.00	1.68	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	74.20	34.45	18.55	0.88	1.32	0.00	1.77	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	82.93	36.26	15.04	1.93	1.16	0.39	1.54	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	55.19	20.76	5.06	1.52	1.01	0.00	0.51	3.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	70.65	27.88	14.42	0.48	0.48	0.96	0.00	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	77.92	30.61	9.54	1.59	0.40	0.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	48.61	21.27	10.33	1.82	1.22	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.89	30.43	6.23	1.38	0.00	2.08	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	73.72	37.62	12.16	1.14	0.38	0.00	0.76	3.80
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	44.41	20.14	12.39	2.07	1.03	0.00	0.52	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	55.02	30.23	13.30	0.00	0.60	0.00	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	75.42	30.74	12.36	0.00	2.22	0.32	0.95	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	58.64	22.92	10.13	0.00	0.53	1.07	0.53	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	47.70	32.76	12.64	0.57	0.57	0.57	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	89.99	40.11	14.91	0.51	2.06	0.51	1.03	3.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	50.93	25.46	9.20	0.71	1.41	0.00	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	61.29	41.99	22.70	0.00	0.57	0.57	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	91.11	34.11	19.55	0.83	0.42	0.42	0.83	2.50
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	53.25	26.62	14.88	0.00	0.00	1.57	4.70	2.35
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	51.36	35.91	12.11	0.00	2.09	0.42	0.42	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	84.56	26.02	13.01	0.00	0.00	0.93	2.32	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	40.81	24.75	14.72	1.34	0.67	0.67	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	57.74	52.39	12.30	0.53	0.53	2.14	1.07	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	83.65	40.01	12.53	1.21	1.21	0.00	1.21	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	53.23	32.12	10.10	0.00	0.92	0.92	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	56.90	45.34	21.34	0.00	2.67	0.00	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	99.16	41.60	13.11	0.57	1.14	0.00	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	63.65	32.21	10.74	0.00	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	57.45	45.42	12.59	0.55	0.00	0.00	0.00	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	96.66	43.65	15.59	0.00	0.45	0.00	1.34	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	79.81	38.47	17.94	0.26	0.26	0.52	0.00	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	76.92	67.64	19.23	0.66	0.00	0.00	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	85.22	58.20	16.63	0.00	0.00	2.08	0.00	6.24
Macrophage - monocyte derived, donor1	11232-116C8	23.93	2.96	12.08	0.46	0.23	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	19.27	3.85	6.24	0.18	0.00	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	33.82	6.29	9.31	0.00	0.00	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	14.34	4.25	1.59	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	48.64	11.88	3.01	0.16	0.00	0.00	0.32	0.32
Mallassez-derived cells, donor3	11930-125I4	53.65	12.23	4.03	0.14	0.00	0.28	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	66.06	30.79	3.09	0.30	0.30	0.20	0.20	0.40
Mammary Epithelial Cell, donor2	11350-117G9	74.41	28.67	4.05	0.29	0.58	0.00	0.58	0.58
Mammary Epithelial Cell, donor3	11422-118F9	59.86	33.67	6.73	0.00	0.00	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	117.96	56.27	4.75	0.00	7.46	0.68	0.68	0.68
Mast cell, donor1	11563-120D6	70.40	45.74	14.27	0.11	0.43	1.08	0.65	0.43
Mast cell, donor2	11565-120D8	58.25	39.52	33.28	0.59	1.19	3.57	0.89	0.59
Mast cell, donor3	11566-120D9	66.86	47.05	31.29	1.35	0.45	1.80	1.13	0.45
Mast cell, donor4	11567-120E1	60.10	42.90	32.44	0.89	1.24	2.30	0.53	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	56.11	38.48	12.42	0.44	0.89	0.55	0.44	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	36.77	40.27	4.09	2.33	1.75	1.75	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	40.27	24.32	14.57	0.46	1.26	1.49	1.15	0.23
Mast cell, expanded, donor8	11941-126A6	43.01	25.94	14.73	0.67	2.01	2.01	1.67	0.67
Melanocyte - dark, donor1	11502-119F8	46.17	18.81	4.68	0.10	0.00	0.10	0.10	0.20
Melanocyte - dark, donor2	11582-120F7	47.76	12.81	2.42	0.00	0.00	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	70.63	38.97	7.46	0.43	0.22	0.14	0.14	0.29
Melanocyte - light, donor1	11274-116H5	68.41	32.68	5.88	0.24	0.24	1.65	0.47	0.71
Melanocyte - light, donor2	11351-117H1	66.88	27.30	6.14	0.00	1.36	2.73	0.00	0.00
Melanocyte - light, donor3	11423-118G1	48.56	31.22	6.07	0.00	1.73	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	60.39	24.57	4.58	0.10	0.21	0.42	0.42	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	42.49	19.09	1.61	0.00	0.27	0.00	0.27	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	65.62	32.68	3.48	0.00	0.54	1.07	0.00	0.54
Meningeal Cells, donor1	11493-119E8	112.77	75.92	13.15	0.12	0.25	0.25	0.12	0.37
Meningeal Cells, donor2	11573-120E7	106.96	62.94	13.64	0.44	0.44	1.32	0.44	0.00
Meningeal Cells, donor3	11654-122E7	63.41	33.82	6.36	0.00	0.24	0.24	0.08	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	45.91	20.53	7.13	0.00	0.29	0.00	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	33.31	10.37	4.63	0.40	0.10	0.20	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	80.16	39.42	13.14	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	98.11	32.70	10.47	0.00	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	58.84	15.07	8.61	0.00	2.15	0.00	1.44	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	52.52	13.55	5.51	0.21	0.21	0.64	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	40.71	14.58	3.52	0.00	0.00	0.50	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	101.97	41.53	8.79	0.00	0.00	0.00	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	99.36	36.53	9.50	0.00	0.00	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	88.80	35.19	8.18	0.00	0.00	0.20	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	25.35	13.02	7.76	0.14	0.14	0.14	0.14	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	75.46	25.28	9.29	0.74	0.37	1.49	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	41.58	26.18	3.68	0.26	0.53	0.13	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	55.49	21.96	5.04	0.00	0.00	0.00	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	44.38	14.01	2.34	0.00	2.34	0.00	2.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	75.57	37.14	5.76	0.00	0.64	0.00	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	37.22	15.60	6.38	0.00	0.00	0.00	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	34.09	20.01	4.69	0.31	0.00	0.00	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	52.25	26.85	3.63	0.00	0.00	0.00	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	32.62	9.02	5.30	0.53	0.00	0.00	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	39.04	9.01	5.00	1.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	38.30	11.35	4.84	0.07	0.36	0.00	0.00	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	44.56	6.75	2.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	30.78	10.10	10.10	0.00	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	29.15	10.60	10.60	0.00	0.59	0.59	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	13.83	6.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	18.29	4.96	6.20	0.00	0.00	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	17.63	3.53	6.85	0.21	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	37.06	6.95	6.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	25.53	7.51	10.26	0.00	0.00	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	24.67	6.05	10.71	0.00	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	23.98	9.14	5.89	0.00	0.20	0.41	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.42	4.75	6.34	0.00	0.00	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	15.93	4.42	5.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	15.96	3.80	5.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	7.90	9.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	15.92	5.31	4.03	0.00	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	0.00	9.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.78	4.47	5.96	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	0.00	8.38	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.81	4.27	4.01	0.00	0.50	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.59	4.04	3.33	0.00	0.00	0.24	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	32.07	3.87	3.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	25.56	4.84	2.99	0.00	0.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.51	3.16	6.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	34.04	7.34	3.26	0.00	0.00	0.20	0.41	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	21.45	3.65	3.22	0.21	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	25.12	5.11	5.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	26.06	6.13	4.16	0.00	0.00	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	28.90	5.07	3.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	38.11	14.91	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	33.70	5.98	4.89	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.53	3.53	4.41	0.00	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	29.44	4.36	1.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.74	5.29	2.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	23.61	2.40	3.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	27.42	13.71	2.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	24.53	5.01	2.00	0.00	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	107.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	10.19	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.39	3.94	0.88	0.00	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	18.76	3.31	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	31.38	8.97	5.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	20.83	3.72	2.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	6.26	2.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	39.78	13.26	6.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.98	7.18	3.08	0.00	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.07	5.69	5.69	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	33.02	10.65	3.91	0.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	23.01	4.77	5.33	0.00	0.28	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	18.29	4.57	5.40	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	29.72	8.16	4.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.47	8.45	4.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.86	3.76	4.17	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	17.55	4.62	5.54	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	22.76	7.40	3.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	34.96	9.67	5.11	0.00	0.14	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	24.62	3.89	6.22	0.00	0.00	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	28.31	8.15	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	31.76	8.89	6.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	22.15	6.14	3.47	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	40.71	6.29	9.88	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	31.50	6.78	5.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	19.11	5.73	4.46	0.00	0.32	0.00	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.86	7.30	5.09	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	30.34	11.38	4.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.44	6.82	1.70	0.28	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.30	8.11	5.90	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	49.53	9.78	5.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	32.93	5.88	6.17	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	46.13	8.36	10.09	0.00	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	39.57	7.83	7.42	0.00	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.99	6.85	10.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	7.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	0.00	3.56	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	31.87	8.87	8.87	0.00	0.33	0.00	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	18.94	1.05	3.16	0.00	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	12.26	3.16	4.15	0.20	0.00	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	6.52	3.73	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.90	4.51	7.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	17.05	5.33	3.46	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.30	3.17	5.09	0.11	0.00	0.00	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	8.84	7.37	0.00	0.00	0.00	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.92	8.06	7.33	0.00	0.00	0.73	0.00	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	24.89	4.67	9.33	0.00	0.00	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	1.60	0.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	0.00	7.73	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	30.30	8.08	7.07	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	7.59	2.11	2.95	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.81	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	11.42	5.71	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	6.52	13.05	6.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	138.04	25.10	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	51.70	20.90	4.52	0.00	0.22	0.22	0.65	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	36.06	12.02	1.05	0.00	0.00	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	39.38	8.68	2.00	0.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	28.38	9.18	2.50	0.00	0.83	0.00	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	40.88	14.83	3.80	0.00	0.00	0.00	0.38	1.71
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	110.11	39.90	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	4.76	2.04	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	45.94	45.94	3.68	0.00	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.09	6.70	2.93	0.42	0.42	0.00	0.00	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	28.59	12.32	2.56	0.46	0.23	0.46	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	29.18	11.08	2.16	0.54	0.27	0.00	0.54	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	59.08	14.09	4.63	0.00	0.00	0.00	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	33.40	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	22.34	8.93	2.48	0.50	0.50	0.50	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	18.95	5.95	1.08	0.00	0.00	0.27	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.95	4.76	1.59	0.00	0.00	0.00	0.00	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	19.27	12.41	1.14	0.00	0.00	0.16	0.00	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	42.10	16.40	3.83	0.00	0.00	0.18	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.99	6.90	2.65	0.53	0.00	0.53	0.00	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	20.41	1.80	3.00	0.60	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.03	7.22	1.64	0.66	0.98	0.00	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.68	6.99	2.11	0.16	0.33	0.00	0.00	1.30
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	63.14	20.11	5.47	0.18	0.88	0.00	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	16.17	4.22	0.70	0.00	0.00	0.00	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	11.49	6.44	3.22	0.00	0.46	0.46	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.85	10.28	1.93	0.00	0.00	0.32	0.00	1.61
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	28.28	10.35	2.41	0.00	0.69	0.34	1.03	3.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	108.72	83.44	10.11	0.00	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	57.92	18.05	6.02	0.00	0.00	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.97	6.35	0.85	0.42	0.42	0.00	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	12.34	5.46	1.66	0.71	0.00	0.24	0.00	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.46	6.01	4.29	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	18.06	0.00	0.00	9.03	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.66	8.33	3.67	0.00	0.33	0.00	0.33	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	50.50	15.78	4.51	0.90	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	6.35	0.79	0.40	0.00	0.40	0.40	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	16.72	12.07	3.71	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	17.78	5.30	2.27	0.38	0.00	0.00	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.46	7.17	1.96	0.00	0.00	0.00	0.00	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	29.63	15.69	5.67	0.00	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	50.20	20.35	8.14	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	7.94	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	11.30	1.99	1.33	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.31	9.92	1.98	0.00	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.06	9.57	2.30	0.00	0.00	0.00	0.00	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	26.62	7.86	3.63	0.00	0.00	0.30	0.30	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	45.53	12.60	4.86	0.22	0.22	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	4.07	2.03	0.00	0.00	0.68	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	35.77	10.22	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	5.49	2.44	0.61	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	26.44	6.61	0.94	0.00	0.00	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	21.19	6.66	3.33	0.30	0.30	0.00	0.00	1.51
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	6.33	0.79	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	24.94	5.67	0.00	2.27	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	32.55	9.94	3.73	0.12	0.37	0.00	0.00	0.50
Myoblast, donor2	11322-117D8	48.52	18.99	5.75	0.19	0.19	0.19	0.38	1.15
Myoblast, donor3	11398-118D3	58.18	19.51	8.41	0.17	0.17	0.00	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	82.45	40.72	11.67	0.15	0.15	0.00	0.29	0.44
Natural Killer Cells, donor1	11230-116C6	71.65	26.14	21.53	1.54	0.00	0.31	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	71.17	27.74	25.33	0.30	0.00	0.60	0.60	0.60
Natural Killer Cells, donor3	11387-118C1	75.28	30.74	19.88	0.00	0.37	0.00	0.74	0.55
Neural stem cells, donor1	11275-116H6	78.03	60.97	5.44	0.73	0.73	1.09	0.36	0.00
Neural stem cells, donor2	11352-117H2	150.20	96.28	17.33	3.85	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	89.89	52.34	10.24	0.00	1.14	0.00	1.14	2.28
Neurons, donor2	11574-120E8	68.25	41.17	14.31	1.98	0.00	0.00	0.44	1.10
Neurons, donor3	11655-122E8	62.48	37.82	2.47	4.93	0.00	0.00	0.00	2.47
Neutrophils, donor1	11233-116C9	103.01	11.14	50.11	6.50	0.00	2.78	0.00	4.64
Neutrophils, donor2	11314-117C9	72.47	5.80	49.28	2.90	5.80	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	187.53	21.38	59.25	3.05	1.22	1.22	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	49.04	26.72	7.60	0.36	0.36	0.12	0.71	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	36.79	18.23	5.21	0.33	0.00	0.65	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	34.29	25.47	6.02	0.00	0.00	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	18.72	12.66	2.20	0.00	0.28	0.28	0.28	0.83
Olfactory epithelial cells, donor2	11934-125I8	31.55	16.21	3.18	0.29	0.00	0.14	0.72	1.01
Olfactory epithelial cells, donor3	11935-125I9	31.33	11.46	3.63	0.23	0.23	0.00	0.11	0.34
Olfactory epithelial cells, donor4	11936-126A1	46.75	22.30	3.60	0.19	0.19	0.29	0.19	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	66.80	26.48	7.22	0.00	0.00	0.00	0.00	0.60
Osteoblast - differentiated, donor1	11276-116H7	32.12	14.04	8.93	0.85	0.21	0.64	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	26.29	5.72	8.00	1.14	1.14	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	30.41	12.41	4.34	0.00	0.00	1.24	0.00	0.62
Osteoblast, donor1	11277-116H8	65.28	31.07	6.25	0.78	0.20	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	70.93	26.69	11.24	0.00	0.00	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	89.40	41.23	8.00	0.00	0.18	0.18	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	51.80	17.69	6.57	0.00	0.42	0.42	0.17	0.59
Pericytes, donor1	11491-119E6	76.22	54.30	12.91	0.56	0.45	0.45	0.45	0.45
Pericytes, donor2	11571-120E5	73.12	52.06	22.18	0.23	0.23	0.91	0.68	0.68
Pericytes, donor3	11652-122E5	76.29	25.84	10.78	0.20	1.02	0.20	0.20	0.81
Perineurial Cells, donor1	11499-119F5	73.69	35.04	5.88	0.11	0.34	0.11	0.23	0.45
Perineurial Cells, donor2	11579-120F4	51.34	21.81	5.70	0.09	0.09	0.18	0.18	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	60.88	21.04	23.59	0.96	0.32	0.32	0.32	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	41.14	17.87	15.43	0.24	0.73	0.49	0.73	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	69.63	22.78	17.73	0.26	0.65	0.26	0.26	0.26
Placental Epithelial Cells, donor1	11278-116H9	50.46	19.37	5.98	1.67	0.24	0.00	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	52.12	21.07	5.54	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	72.64	34.55	7.07	0.00	0.79	0.59	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.99	5.06	4.75	0.00	0.00	0.32	0.63	1.58
Preadipocyte - breast, donor1	11467-119B9	15.38	6.75	3.94	0.00	0.19	0.56	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	52.73	20.49	7.70	0.00	0.13	0.00	0.00	0.65
Preadipocyte - breast, donor2	11328-117E5	31.97	13.96	3.38	0.00	0.23	0.23	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	25.25	11.30	4.26	0.53	0.32	0.53	0.21	0.43
Preadipocyte - omental, donor2	11329-117E6	30.99	13.97	6.55	0.87	0.00	0.00	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	48.27	13.04	6.30	0.00	0.29	0.72	0.43	0.72
Preadipocyte - perirenal, donor1	11469-119C2	29.53	19.69	5.91	0.00	0.98	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	93.98	31.94	9.83	0.00	0.00	1.23	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	78.09	28.16	9.74	0.00	0.18	0.18	0.53	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	51.77	18.56	4.77	0.00	0.00	0.34	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	66.23	27.01	6.43	0.09	0.37	0.28	0.28	0.28
Preadipocyte - visceral, donor2	11357-117H7	50.16	18.41	5.06	0.46	1.38	0.92	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	47.54	25.60	5.12	0.00	0.10	0.21	0.42	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	68.64	29.87	3.62	0.45	0.91	2.11	0.91	1.96
Prostate Epithelial Cells, donor2	11331-117E8	46.72	11.92	4.87	0.00	0.95	0.68	0.54	0.54
Prostate Epithelial Cells, donor3	11404-118D9	35.46	13.96	10.29	0.00	0.73	0.80	0.86	0.61
Prostate Stromal Cells, donor1	11254-116F3	61.05	18.79	5.58	0.11	0.23	0.46	0.23	0.57
Prostate Stromal Cells, donor2	11332-117E9	60.24	20.26	5.38	0.72	0.18	0.36	0.90	2.33
Prostate Stromal Cells, donor3	11405-118E1	42.23	13.24	6.67	0.21	0.73	0.94	0.31	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	94.90	46.72	12.41	0.73	0.00	0.00	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.07	20.72	5.54	0.00	0.28	0.14	0.14	0.28
Renal Epithelial Cells, donor1	11517-119H5	181.08	60.87	17.25	0.00	0.51	1.52	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	84.65	29.88	6.40	0.00	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	47.11	23.61	4.13	0.53	0.00	0.21	0.11	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	70.13	32.68	5.45	0.00	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	69.54	30.32	4.18	0.13	0.40	0.13	0.40	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	82.37	29.75	5.77	0.00	0.22	0.00	0.00	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	95.16	32.61	11.31	0.00	0.67	1.33	1.33	2.66
Renal Mesangial Cells, donor1	11518-119H6	111.36	37.86	9.46	0.44	0.00	0.22	0.22	0.44
Renal Mesangial Cells, donor2	11598-120H5	102.83	36.99	7.52	0.00	0.00	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	92.66	32.18	10.26	0.00	0.55	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	85.90	29.79	8.05	0.54	0.00	0.27	0.00	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	48.49	26.14	3.37	0.00	0.42	0.42	0.84	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	102.98	34.13	5.59	0.00	0.58	0.58	0.58	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	51.86	19.45	5.44	0.00	0.00	0.26	0.00	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	82.72	34.96	9.10	0.00	0.28	0.28	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	95.71	30.87	7.20	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.36	16.81	3.26	0.00	0.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	34.75	17.37	11.76	0.94	0.27	0.27	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	76.83	33.06	0.89	0.00	0.00	1.79	0.00	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	68.25	23.67	5.50	0.55	2.20	3.85	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	82.37	32.48	6.96	0.00	0.00	1.16	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	140.95	74.50	10.53	0.65	0.78	0.26	0.39	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	135.75	62.76	8.74	0.10	0.79	0.70	0.70	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	123.81	59.34	7.92	0.11	0.45	0.22	0.00	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	147.98	72.69	9.18	0.12	0.50	0.50	0.62	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	132.51	58.74	8.86	0.12	1.05	0.93	0.93	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	158.79	64.02	7.86	0.46	0.23	1.16	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	149.23	77.22	7.80	0.00	0.82	0.68	0.41	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	133.57	59.90	7.26	0.00	1.36	0.91	0.61	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	113.61	51.43	9.50	0.18	0.36	0.18	0.54	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	132.27	70.15	8.89	0.14	0.86	0.43	0.72	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	126.85	58.70	6.76	0.11	0.43	0.43	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	127.45	61.29	8.41	0.00	1.11	0.00	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	141.28	61.37	8.22	0.00	0.38	0.57	0.38	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	146.45	76.21	8.76	0.09	0.37	0.28	0.84	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	116.13	67.83	8.83	0.75	0.19	1.13	0.38	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	164.82	103.64	10.62	0.13	0.27	1.19	0.13	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	148.64	75.44	8.47	0.00	0.88	0.58	1.27	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	144.17	60.15	8.78	0.38	0.95	0.95	0.76	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	143.85	82.66	8.01	0.00	0.32	0.32	0.43	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	121.09	63.91	4.20	0.28	0.28	0.56	0.84	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	148.17	66.65	6.67	0.00	0.68	0.34	0.51	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	130.91	77.31	6.20	0.18	0.00	0.36	0.18	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	129.25	67.94	9.57	0.12	0.37	0.74	1.23	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	148.02	67.29	9.54	0.00	1.07	0.40	0.54	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	129.26	60.15	9.43	0.47	0.94	0.47	0.47	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	128.57	65.67	8.73	0.40	0.40	0.79	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	148.49	62.67	7.02	0.00	2.10	0.47	0.23	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	138.10	60.34	9.33	0.00	0.62	0.83	0.21	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	110.83	65.26	8.41	0.22	1.55	0.88	2.21	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	151.86	61.83	7.94	0.00	0.42	0.84	1.04	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	145.49	85.60	10.36	0.13	0.67	0.40	0.13	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	151.73	78.51	9.54	0.00	0.17	0.34	0.34	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	161.37	71.33	7.52	0.00	0.39	0.96	0.19	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	155.09	62.07	10.83	0.17	1.38	0.17	0.34	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	134.01	71.60	7.82	0.27	1.10	0.82	0.41	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	129.37	60.91	9.36	0.33	1.81	0.33	1.15	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	143.16	67.32	6.99	0.00	1.02	0.85	1.19	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	159.65	73.68	11.69	0.15	0.59	0.89	1.04	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	174.32	75.70	11.20	0.00	0.80	0.00	0.53	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	126.38	93.33	7.60	0.14	0.55	0.97	0.41	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	118.57	59.53	8.33	0.00	0.95	0.95	0.95	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	190.05	91.70	9.47	0.40	0.60	0.81	1.01	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	109.52	74.21	9.13	0.00	1.32	1.32	1.04	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	121.93	79.65	6.99	0.35	2.45	1.40	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	117.56	66.18	7.25	0.00	0.60	0.60	0.91	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	109.78	69.39	6.98	0.12	1.59	2.20	0.49	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	184.71	113.82	12.23	0.29	0.87	0.73	0.44	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	124.12	60.84	7.91	0.61	1.83	2.43	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	109.11	56.36	8.14	0.60	1.81	1.81	1.81	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	119.20	73.96	7.69	0.45	4.75	3.85	1.36	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	140.48	82.97	8.69	0.00	0.60	0.90	0.60	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	92.92	72.50	7.08	1.06	3.42	6.49	1.30	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	111.63	59.55	8.75	0.43	5.76	7.47	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	129.81	63.70	7.81	0.60	2.40	1.80	0.60	1.20
Schwann Cells, donor1	11498-119F4	107.20	63.57	12.22	0.00	0.19	0.94	0.56	0.75
Schwann Cells, donor2	11578-120F3	40.83	34.02	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	59.59	23.00	4.16	0.00	0.44	0.22	0.88	1.31
Sebocyte, donor1	11220-116B5	168.71	75.59	14.24	0.00	0.55	1.10	1.10	0.00
Sebocyte, donor2	11301-117B5	102.48	26.65	8.73	0.00	1.38	1.84	0.92	1.38
Sebocyte, donor3	11378-118B1	74.61	16.49	12.57	0.00	0.62	0.82	0.41	0.41
Sertoli Cells, donor1	11255-116F4	59.64	26.51	3.31	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	42.37	8.47	5.65	0.00	0.00	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	55.25	39.33	6.60	0.18	0.70	0.70	0.26	0.26
Skeletal Muscle Cells, donor2	11358-117H8	47.71	26.75	5.78	0.00	0.72	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	132.09	60.19	14.21	0.84	1.67	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	53.73	25.61	7.23	0.00	0.47	0.16	0.31	0.31
Skeletal Muscle Cells, donor5	11455-119A6	52.77	24.08	5.05	0.00	0.45	0.30	0.89	1.19
Skeletal Muscle Cells, donor6	11459-119B1	63.10	35.40	8.31	0.00	0.15	0.31	0.46	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	51.03	28.35	5.54	0.00	0.00	0.25	0.25	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	60.21	29.39	8.28	0.14	0.71	0.14	0.71	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	84.63	38.59	8.53	0.00	0.40	0.30	0.10	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	64.37	27.21	7.41	0.67	0.51	0.17	0.42	0.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	83.96	46.32	12.30	0.00	0.72	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	54.63	27.52	7.02	0.00	0.14	0.28	0.00	0.28
Skin - palm, donor1	10286-104F7	59.09	45.66	16.12	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.39	5.91	3.60	0.00	0.43	0.14	0.43	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.16	9.00	5.73	0.82	0.00	0.82	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.65	10.91	5.19	0.00	0.78	0.13	0.26	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	29.61	14.73	3.61	0.28	0.56	0.97	0.70	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	50.64	26.72	4.64	0.00	0.56	0.28	0.14	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	101.92	36.58	12.26	0.42	0.00	0.21	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	50.37	28.63	6.52	0.07	0.22	0.37	0.37	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	32.71	11.11	5.25	0.00	0.93	0.31	0.62	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	52.03	23.79	6.45	0.44	1.11	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	81.71	26.45	10.58	0.00	0.00	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	62.54	29.39	14.36	0.44	0.44	0.22	0.22	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	60.64	14.57	6.69	0.39	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	75.71	20.86	13.91	0.00	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	28.02	17.01	2.00	0.00	1.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	47.11	17.70	4.13	0.27	0.27	0.53	0.13	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	42.34	13.74	4.21	0.00	0.22	0.22	0.66	0.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.39	4.74	1.41	0.26	0.13	0.00	0.00	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	31.58	13.35	6.51	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	59.07	15.36	6.79	0.30	0.00	0.00	0.00	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.87	8.83	5.55	0.00	0.28	0.14	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	92.89	33.84	12.20	0.33	0.00	0.65	0.33	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	29.53	20.70	5.18	0.00	0.61	0.30	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	71.98	40.66	8.59	1.52	0.51	0.25	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	446.81	42.84	55.09	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	37.67	21.93	5.25	0.00	0.00	0.48	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	32.59	11.95	3.98	0.44	0.00	0.15	0.15	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	55.53	20.45	2.58	0.00	0.43	0.22	1.08	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	58.04	20.89	4.51	0.00	0.10	0.10	0.52	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	61.72	21.04	11.60	0.62	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	68.98	18.32	7.55	0.00	1.08	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	43.04	17.03	3.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	142.36	56.67	9.90	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.03	19.08	3.85	0.08	0.08	0.00	0.16	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	35.73	16.00	6.24	0.10	0.70	2.31	0.70	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	52.11	11.83	6.83	0.00	0.68	0.46	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	49.51	21.13	6.64	0.60	1.21	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	94.84	30.73	8.74	0.00	0.00	0.26	0.53	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	56.06	24.10	7.59	0.13	0.13	0.40	0.67	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	56.60	16.65	4.51	0.00	1.13	0.63	0.88	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	30.69	12.18	6.34	0.25	1.01	0.00	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	60.31	22.01	6.63	0.15	0.15	0.45	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	60.01	23.26	7.50	0.00	0.00	0.00	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	276.53	160.23	60.73	0.00	6.46	2.58	2.58	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	92.08	40.46	10.70	0.93	0.93	0.00	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	45.44	19.19	5.55	0.00	1.01	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	43.25	16.92	6.58	0.00	0.00	0.63	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	44.25	18.88	9.73	0.00	0.29	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	78.31	40.15	9.66	0.08	0.08	0.17	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	36.91	16.35	5.61	0.00	0.00	0.47	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	49.36	19.00	6.62	0.43	0.29	0.43	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	70.11	23.20	6.12	0.00	0.51	0.51	1.27	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	48.32	28.39	4.70	0.19	0.19	0.56	0.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	67.36	30.60	10.06	0.14	0.14	0.00	0.14	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	49.35	21.78	5.03	0.00	0.00	0.00	0.08	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	54.76	19.52	7.14	0.00	0.95	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	48.44	22.75	3.43	0.24	0.49	0.24	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.64	13.70	6.19	0.00	0.22	0.22	0.22	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	67.29	31.60	7.90	0.00	0.29	0.00	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	24.10	7.19	3.30	0.00	0.19	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	30.15	4.76	2.12	0.26	0.00	0.00	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	15.25	3.35	1.12	0.00	1.12	0.74	0.37	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	37.01	6.83	2.52	0.00	0.36	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	37.19	8.52	4.26	0.00	0.28	0.57	0.00	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	40.57	10.24	1.18	0.00	0.00	0.39	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	18.79	4.32	3.05	0.00	0.51	0.51	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	15.57	7.59	4.79	0.00	0.00	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	16.30	2.51	2.93	0.42	0.42	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	19.25	4.58	1.38	0.00	0.00	0.46	0.00	0.92
Synoviocyte, donor1	11291-117A4	33.33	12.96	2.86	0.00	0.17	0.50	0.34	1.01
Synoviocyte, donor2	11368-117I9	32.35	9.22	4.19	0.17	0.17	0.34	0.17	0.17
Synoviocyte, donor3	11440-118H9	27.03	11.62	4.47	0.00	0.00	0.00	0.67	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	176.88	65.03	11.43	0.36	0.00	0.00	0.36	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	107.03	43.60	9.91	0.00	0.00	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	130.13	64.60	9.72	0.23	0.69	0.00	0.00	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	49.46	20.93	5.30	0.07	0.14	0.22	0.14	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	61.46	20.87	3.87	0.00	0.00	0.00	0.77	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	52.11	29.21	5.15	0.57	0.57	0.57	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	31.13	16.24	10.58	0.74	1.23	0.86	0.49	0.12
Urethra, donor2	10319-105A4	57.55	48.56	10.79	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	83.15	31.61	6.64	0.80	0.27	0.27	0.00	0.80
Urothelial Cells, donor2	11600-120H7	66.49	22.03	5.21	0.40	0.80	0.00	0.40	0.80
Urothelial Cells, donor3	11681-122H7	76.78	26.13	5.04	0.00	0.23	0.23	0.46	0.92
Urothelial cells, donor0	11216-116B1	57.51	25.63	6.91	0.00	0.00	0.45	0.67	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	65.84	14.24	32.03	5.34	0.00	0.00	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	71.48	14.30	38.60	10.01	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	60.92	8.90	21.90	0.00	0.68	0.00	1.37	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	49.93	14.12	27.55	5.51	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	35.44	9.30	16.85	5.81	0.00	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	54.14	11.45	24.99	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	62.41	17.44	29.37	5.51	0.00	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	12.78	27.39	0.00	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	100.42	58.72	5.92	0.12	0.37	0.49	0.25	1.11
Wilms' tumor cell line:HFWT	10597-108E3	85.36	72.16	8.80	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	113.40	53.63	13.97	0.00	0.28	0.28	0.28	1.12
achilles tendon, donor2	10292-104G4	62.00	26.86	6.20	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	118.55	49.21	15.04	1.27	0.76	0.51	0.76	1.78
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	140.23	46.67	20.20	0.46	0.70	0.23	0.00	1.39
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	152.66	71.11	14.24	0.71	0.36	0.36	0.24	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	120.00	41.91	7.35	0.27	0.82	0.27	0.00	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	189.45	87.98	12.09	0.00	2.25	1.12	0.56	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	73.38	25.38	9.09	0.00	0.00	0.00	0.21	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	155.43	26.68	6.53	0.27	0.82	0.00	1.09	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	131.31	40.54	12.78	0.00	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	119.24	54.31	10.21	0.41	0.41	0.82	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	119.21	62.90	14.37	0.78	0.78	0.78	0.78	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	93.47	36.43	8.65	0.18	0.92	0.37	0.18	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	163.82	66.31	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	163.13	65.30	6.97	0.23	0.46	0.00	1.39	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	263.56	73.79	21.23	1.04	1.04	0.52	0.78	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	130.34	33.32	12.27	0.00	0.88	0.29	0.58	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	90.63	37.65	8.83	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	81.43	25.09	11.52	0.00	0.00	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	97.61	52.18	12.58	0.31	0.00	0.31	0.61	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	150.20	68.27	14.93	0.43	0.43	0.00	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	152.56	81.28	21.53	0.00	0.61	0.00	0.61	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	173.31	88.58	21.66	0.00	0.00	0.24	0.48	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	148.57	42.77	10.69	0.22	0.22	0.00	1.34	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	115.41	32.69	8.01	0.00	0.33	0.67	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	191.39	87.34	18.58	0.00	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	128.82	34.28	10.92	0.00	0.38	0.75	1.51	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	136.95	64.11	17.01	0.00	0.44	0.00	0.00	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	206.19	74.98	37.49	0.00	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	69.24	44.51	17.43	0.00	0.47	0.00	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	32.26	15.36	14.12	1.40	1.55	1.40	0.31	0.31
adipose, donor1	10184-103D4	85.62	38.70	4.69	0.00	4.10	3.52	2.35	2.35
adipose, donor2	10185-103D5	55.56	28.79	6.08	0.81	1.62	1.62	0.41	3.24
adipose, donor3	10186-103D6	80.05	32.67	7.08	0.00	1.09	1.91	0.82	1.91
adipose, donor4	10187-103D7	223.62	34.67	9.53	0.00	3.47	3.47	0.00	4.33
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	109.37	42.77	14.84	0.32	0.16	0.47	0.47	0.16
adrenal gland, adult, pool1	10081-102A9	25.46	25.46	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	81.64	40.96	10.67	0.27	1.07	0.27	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	83.25	61.46	4.29	0.00	0.71	0.36	0.36	1.07
amniotic membrane cells, donor1	12235-129G3	32.46	11.59	12.75	0.70	0.70	0.00	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	74.38	25.70	9.47	1.01	0.00	0.34	0.68	1.01
amniotic membrane cells, donor3	12237-129G5	29.17	5.89	15.02	0.00	0.29	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	134.00	24.90	13.04	2.37	1.19	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	121.25	64.68	24.53	2.84	1.01	0.20	0.61	1.01
amygdala, newborn, donor10223	10360-105E9	42.93	18.08	7.42	0.00	0.00	0.32	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	35.40	17.95	11.84	0.64	0.51	0.25	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	153.11	66.85	13.90	0.66	0.44	0.44	0.66	2.43
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	161.34	126.93	8.68	0.00	0.33	0.00	0.33	1.00
aorta, adult, pool1	10052-101G7	53.74	32.95	14.91	0.98	0.39	0.39	0.39	0.39
appendix, adult	10189-103D9	86.94	25.62	16.69	1.55	0.39	0.39	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	109.37	57.78	9.97	0.00	1.03	0.34	0.00	0.69
artery, adult	10190-103E1	36.68	19.02	12.23	0.00	0.00	1.36	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	85.04	90.11	4.49	0.43	0.29	0.14	0.14	0.29
b cell line:RPMI1788	10427-106D4	90.41	32.86	15.02	0.15	0.45	0.59	0.45	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.74	14.15	3.61	0.28	0.28	0.00	0.00	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	84.25	41.88	9.23	0.00	0.10	0.40	0.10	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	28.62	30.30	3.35	0.33	0.17	0.33	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	91.72	22.37	7.83	0.00	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	44.65	29.22	13.91	3.04	0.65	0.98	0.11	0.22
blood, adult, pool1	10053-101G8	31.00	4.43	6.64	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	65.08	47.10	8.56	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	36.44	12.82	11.47	0.00	0.67	0.00	1.35	1.35
brain, adult, donor1	10084-102B3	58.43	44.08	19.48	1.03	0.00	1.03	1.03	1.03
brain, adult, pool1	10012-101C3	76.28	46.88	19.38	5.01	0.45	0.56	0.45	0.89
brain, fetal, pool1	10085-102B4	93.50	66.78	40.07	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	61.45	19.16	17.51	0.00	0.33	0.33	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	155.53	57.17	15.73	1.25	0.12	0.37	0.62	0.00
breast, adult, donor1	10080-102A8	35.99	16.42	3.79	1.26	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	36.33	45.23	9.15	0.13	0.25	0.13	0.13	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	62.46	49.78	7.42	0.00	0.93	0.00	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	68.84	24.63	5.30	0.46	2.30	0.46	1.15	2.99
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	55.68	50.60	9.44	0.73	0.48	0.00	0.00	0.73
carcinoid cell line:NCI-H1770	10703-109H1	92.15	39.49	7.52	0.00	0.00	0.00	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	70.55	46.60	6.02	0.11	0.11	0.66	0.11	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	84.29	49.75	6.97	0.32	0.32	0.32	0.32	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	107.27	64.42	10.38	0.27	0.27	1.86	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	81.74	34.54	11.51	2.30	1.15	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	102.74	56.72	22.59	0.67	0.17	0.00	0.33	1.00
caudate nucleus, adult, donor10258	10379-105H1	57.31	37.44	15.28	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	47.61	17.58	4.76	0.73	0.37	0.37	0.37	1.46
cerebellum - adult, donor10196	10173-103C2	122.36	61.18	14.57	5.83	2.91	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	164.83	77.08	24.98	4.27	1.07	0.64	1.92	0.85
cerebellum, adult, pool1	10083-102B2	52.09	49.67	15.18	3.79	0.34	0.00	0.69	0.69
cerebellum, newborn, donor10223	10357-105E6	39.02	25.74	9.13	3.32	0.83	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	53.96	30.00	10.59	1.26	0.25	0.00	0.25	0.25
cerebrospinal fluid, donor2	10294-104G6	29.97	22.66	5.85	1.46	0.00	0.00	0.73	2.19
cervical cancer cell line:D98-AH2	10552-107I3	78.65	52.05	11.93	0.14	0.14	0.00	0.43	0.58
cervical cancer cell line:ME-180	10553-107I4	48.06	23.37	4.97	0.33	0.00	0.17	0.17	0.17
cervix, adult, pool1	10013-101C4	72.55	48.93	17.43	4.51	0.73	1.57	0.52	0.31
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	52.81	17.14	8.64	1.11	0.00	0.14	0.00	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	61.39	27.43	3.92	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	82.15	42.13	13.67	0.00	0.87	1.12	1.37	1.86
choriocarcinoma cell line:SCH	10785-110H2	169.42	90.31	7.89	0.12	0.62	0.74	0.62	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	65.22	38.90	4.98	0.24	0.00	0.00	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	39.03	20.23	8.83	0.57	0.57	0.00	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	74.77	35.80	6.16	0.40	1.49	0.80	0.20	0.99
chorionic membrane cells, donor3	12240-129G8	35.72	26.38	12.64	0.55	1.10	0.55	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	56.55	24.24	9.09	0.00	1.01	0.00	1.01	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	132.16	70.88	13.64	0.58	0.38	0.00	0.77	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	135.16	80.46	16.47	0.42	0.63	0.63	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	148.17	58.81	12.58	0.00	0.51	0.26	0.51	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	167.38	70.63	11.37	0.00	0.00	0.24	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	142.12	63.93	13.85	0.20	0.81	0.81	0.61	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	111.01	60.07	13.84	0.00	0.59	0.29	0.00	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	219.19	107.12	34.66	1.30	0.26	1.30	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.32	27.43	10.06	0.23	0.46	0.46	0.69	1.37
clear cell carcinoma cell line:TEN	10636-108I6	39.39	17.18	9.02	0.69	0.69	0.00	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	68.27	35.14	4.76	0.18	0.55	0.18	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	120.87	79.82	6.84	0.38	0.38	1.14	0.00	0.00
colon, adult, donor1	10082-102B1	42.84	30.94	9.52	0.00	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	49.12	31.73	15.28	1.06	0.71	1.41	0.00	0.59
colon, fetal, donor1	10070-101I7	17.92	19.78	9.27	0.62	0.00	1.85	0.62	1.85
common myeloid progenitor CMP, donor1	12130-128D6	302.51	183.34	22.92	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	76.91	48.44	2.97	0.00	0.00	0.42	0.00	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	50.41	45.28	3.02	0.30	0.00	0.15	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	54.43	48.08	5.22	0.85	0.14	0.00	0.28	0.42
corpus callosum, adult, pool1	10042-101F6	101.39	71.53	27.31	2.21	0.55	0.44	0.00	0.44
cruciate ligament, donor2	10295-104G7	51.87	25.12	17.02	0.00	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	36.12	23.27	11.24	2.41	0.00	0.00	0.80	1.61
diencephalon, adult	10193-103E4	52.80	33.12	13.44	0.48	0.00	0.48	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	85.64	38.12	10.56	0.00	0.46	0.23	2.53	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	58.72	40.00	12.31	0.51	0.51	0.51	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	98.70	20.22	4.57	0.00	0.00	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	53.82	38.37	9.47	1.50	1.00	0.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	31.69	23.04	7.20	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	62.53	25.75	15.45	0.00	0.00	1.47	1.47	0.74
dura mater, adult, donor1	10041-101F5	50.38	39.72	15.86	0.17	0.33	0.50	0.25	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	265.15	64.40	8.66	0.89	4.44	4.66	2.44	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	176.82	29.38	10.60	1.15	0.72	2.01	1.15	1.29
embryonic pancreas cell line:1B2C6	10604-108F1	56.11	62.28	5.55	0.00	0.00	0.62	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	52.97	55.09	4.54	0.00	0.00	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	61.44	62.37	4.01	0.00	0.31	0.62	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	95.88	89.32	2.63	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	109.61	63.69	11.06	0.34	0.00	0.00	0.34	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	62.71	39.33	9.24	0.54	0.00	0.18	0.18	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.40	10.13	7.40	0.00	0.32	0.32	0.32	0.48
epidermoid carcinoma cell line:A431	10426-106D3	104.93	36.68	13.56	0.11	0.11	0.33	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	92.28	34.54	14.96	0.22	0.00	0.55	0.33	0.66
epididymis, adult	10197-103E8	47.93	32.65	11.51	0.21	1.05	1.26	0.00	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	74.51	35.13	5.68	0.53	0.35	0.71	0.35	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	56.63	33.03	1.97	0.00	0.00	0.39	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	85.58	52.68	5.64	0.13	0.66	0.26	0.39	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	84.35	61.22	5.31	0.00	0.49	0.10	0.39	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	80.10	49.07	7.84	0.22	0.34	0.34	0.56	0.45
esophagus, adult, pool1	10015-101C6	49.59	24.31	14.02	0.85	0.64	1.49	0.11	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	96.81	74.52	16.78	0.88	0.63	1.00	0.38	0.38
eye - muscle inferior rectus, donor1	10272-104E2	38.63	28.97	7.24	2.41	2.41	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	42.08	44.19	12.63	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	49.11	44.65	10.42	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	33.25	41.27	10.32	1.15	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	37.89	33.52	10.20	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	47.03	30.00	13.73	2.54	0.51	0.25	0.76	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	61.16	40.78	6.03	0.13	0.26	0.26	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	119.18	46.30	17.33	0.24	0.47	0.24	0.00	1.42
frontal lobe, adult, pool1	10040-101F4	104.61	59.86	26.46	1.60	0.09	0.28	0.28	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	106.29	33.93	10.81	0.60	0.90	0.00	0.30	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	94.00	53.31	10.52	0.37	0.18	0.27	0.18	0.09
gall bladder, adult	10198-103E9	59.39	32.59	17.38	0.00	1.69	1.45	0.48	0.72
gamma delta positive T cells, donor1	11937-126A2	46.71	21.47	15.03	4.29	0.54	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	40.34	15.31	13.07	5.60	0.37	0.37	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	65.69	33.37	9.93	0.00	0.21	0.63	0.84	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	147.38	129.40	24.95	0.19	0.19	0.19	0.19	1.35
gastric cancer cell line:AZ521	10549-107H9	128.21	50.66	8.53	0.66	0.33	0.33	0.16	0.33
gastric cancer cell line:GSS	10560-108A2	65.90	34.78	4.58	0.92	0.92	0.00	0.92	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	92.53	39.75	6.40	0.46	0.46	0.46	0.69	0.91
giant cell carcinoma cell line:LU65	10487-107B1	41.19	29.03	7.57	0.23	0.11	0.23	0.34	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	146.54	48.71	20.43	0.28	0.70	0.84	0.56	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	60.61	51.88	8.23	0.00	0.25	1.25	0.00	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	67.66	35.68	4.86	0.00	0.42	0.32	0.53	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	66.01	41.57	6.46	0.14	0.14	0.56	0.28	0.14
glioblastoma cell line:T98G	10485-107A8	63.35	46.58	4.30	0.22	0.22	0.11	0.00	0.22
glioma cell line:GI-1	10413-106B8	98.99	39.25	6.74	0.29	1.17	0.29	0.00	0.88
globus pallidus - adult, donor10196	10175-103C4	71.43	40.09	9.48	2.92	0.00	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	118.87	56.63	28.56	1.22	1.46	0.24	0.00	0.24
globus pallidus, adult, donor10258	10367-105F7	38.34	27.38	6.85	0.00	0.00	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	35.71	15.99	4.80	0.53	0.00	0.53	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	313.23	149.28	63.63	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	43.71	10.93	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	10.45	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	61.76	30.08	4.80	0.00	0.32	0.00	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	131.77	36.27	6.89	0.00	0.92	0.00	0.92	0.46
hIPS +CCl2, biol_rep2	14384-156C1	132.15	29.72	7.32	0.00	0.46	0.00	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	100.48	21.90	5.80	0.00	0.00	0.00	2.58	0.00
hIPS, biol_rep1	14380-156B6	70.43	7.19	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	88.48	19.20	2.74	0.00	0.00	0.00	0.69	1.37
hIPS, biol_rep3	14382-156B8	81.66	25.38	12.14	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	87.93	30.46	9.19	0.00	0.29	0.00	0.00	0.57
heart - mitral valve, adult	10205-103F7	59.20	33.19	8.37	0.30	0.30	0.00	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	53.08	41.05	15.17	0.52	0.52	0.78	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	69.11	40.80	17.49	0.00	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	68.15	36.53	15.10	0.61	0.82	0.61	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	45.99	36.62	12.35	0.43	0.43	0.85	1.70	0.43
heart, adult, pool1	10016-101C7	47.15	29.44	13.11	0.69	0.23	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	100.32	74.03	20.74	0.92	0.31	0.31	0.10	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	43.19	14.81	4.94	0.00	0.31	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	66.59	52.32	7.14	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	141.88	46.96	11.38	0.22	0.33	0.00	0.33	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	140.79	50.01	10.56	0.12	0.61	0.12	0.85	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	152.69	56.29	11.22	0.10	0.30	0.51	1.11	0.71
hepatoma cell line:Li-7	10484-107A7	83.86	48.05	4.23	0.11	0.33	0.11	0.56	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	106.33	30.35	12.66	0.20	0.20	0.00	0.30	0.40
hippocampus - adult, donor10196	10169-103B7	76.65	24.60	17.03	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	124.30	63.68	25.51	1.84	0.41	0.41	0.61	1.02
hippocampus, adult, donor10258	10374-105G5	84.15	25.89	5.48	0.00	1.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	51.11	22.91	9.16	0.70	0.70	0.70	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	92.77	25.63	4.27	0.61	2.44	1.22	1.83	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	98.96	26.31	8.64	0.20	1.37	0.39	0.98	2.36
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	102.57	31.23	7.36	0.51	0.76	2.54	0.51	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	84.58	34.96	3.38	0.00	3.38	2.82	2.82	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	112.32	47.77	9.81	1.03	8.26	7.75	4.13	8.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	94.52	34.54	7.59	0.38	7.21	7.21	2.28	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	78.83	43.79	6.13	0.58	4.67	3.21	1.46	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	86.60	51.49	10.34	0.65	5.82	4.74	1.94	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	65.48	30.03	5.00	0.00	1.67	1.25	1.25	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	56.12	31.02	4.74	0.95	2.13	0.95	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	77.63	39.70	9.16	0.48	2.09	4.02	0.48	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	55.21	29.63	6.06	0.67	2.02	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	94.20	34.58	10.17	0.47	2.19	2.03	1.25	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	92.36	30.46	5.40	0.98	3.93	1.97	2.95	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	45.38	9.60	0.00	0.00	2.62	4.36	2.62	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	130.58	47.54	8.59	0.95	4.96	5.15	3.05	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	110.76	40.12	6.54	0.44	3.92	4.80	2.18	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	78.46	29.49	6.50	0.50	3.50	6.00	2.50	4.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	72.34	28.64	10.74	0.19	3.39	3.20	2.07	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	66.84	30.47	10.91	0.91	3.64	0.45	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	60.77	21.30	8.14	0.63	3.13	2.19	1.25	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	51.93	27.11	5.39	0.65	2.12	3.59	0.49	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	55.74	24.39	6.68	0.29	2.03	1.45	0.29	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	50.52	28.70	6.58	0.30	2.69	3.59	2.09	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	92.37	29.56	5.36	0.37	3.51	0.55	1.85	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	108.98	35.38	7.42	0.00	1.14	2.00	1.14	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	107.79	26.95	5.31	0.00	1.22	0.82	2.45	3.67
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	116.54	46.47	9.15	0.35	3.87	5.28	3.52	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	103.26	31.99	6.65	0.32	5.70	2.22	0.95	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	84.13	25.12	5.45	0.30	4.84	4.24	1.51	3.93
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	69.29	30.51	6.21	0.00	3.10	1.03	0.52	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	65.75	29.22	5.98	0.00	1.99	0.66	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	55.67	28.99	4.36	0.00	3.08	2.82	1.03	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	65.70	27.87	7.41	0.26	3.32	1.53	2.05	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	74.21	31.05	6.06	0.76	2.27	2.27	0.76	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	32.93	21.51	4.03	0.00	0.67	1.01	0.67	3.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	108.44	38.88	6.76	0.24	2.17	1.69	2.17	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	80.66	21.84	4.46	0.00	3.57	2.67	1.78	3.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	100.00	33.17	8.29	0.00	0.98	3.41	0.98	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	137.83	43.09	9.17	0.00	4.58	3.06	2.14	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	107.36	55.31	3.25	3.25	29.28	9.76	19.52	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	103.58	26.14	7.28	0.33	9.93	7.94	6.62	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	107.27	41.05	8.21	0.00	3.83	2.74	1.09	3.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	69.48	35.10	6.88	0.36	2.53	2.17	0.36	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	67.26	25.27	4.63	0.00	4.98	4.27	0.36	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	32.22	20.29	2.39	1.19	1.19	3.58	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	87.21	45.37	6.77	0.81	4.88	3.93	1.90	1.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	39.87	24.51	3.23	0.54	1.62	1.35	0.81	1.62
immature langerhans cells, donor1	11904-125F5	33.42	10.90	10.41	0.00	0.00	0.00	0.00	0.24
immature langerhans cells, donor2	11905-125F6	72.08	12.67	13.47	0.00	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	138.92	78.26	32.36	1.99	0.57	0.28	0.28	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	56.90	32.19	5.85	0.33	0.00	0.00	0.00	0.65
kidney, adult, pool1	10017-101C8	46.86	28.54	9.11	0.60	0.20	0.30	0.20	0.30
kidney, fetal, pool1	10045-101F9	98.25	55.32	23.41	0.50	0.35	0.42	0.42	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	160.48	89.33	17.33	4.97	0.28	0.71	0.43	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.35	21.84	1.11	0.00	0.28	0.28	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	104.96	69.91	9.91	0.00	0.18	0.92	0.00	0.18
left atrium, adult, donor1	10079-102A7	24.52	26.70	5.99	0.00	0.00	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	29.83	19.21	5.06	0.00	0.00	1.01	0.00	2.53
leiomyoblastoma cell line:G-402	10721-110A1	109.44	50.34	8.48	0.27	0.27	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	27.30	8.98	4.67	0.36	0.00	1.44	1.08	0.36
leiomyoma cell line:15242A	10570-108B3	36.41	7.61	2.17	0.00	0.54	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	32.78	11.41	4.61	0.00	0.24	0.49	0.49	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	19.05	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	102.46	33.46	5.23	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	207.78	68.59	15.94	0.24	0.24	0.59	0.47	1.30
liposarcoma cell line:KMLS-1	10782-110G8	45.93	15.46	2.66	0.16	0.00	0.00	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	97.23	69.81	6.70	0.12	0.61	0.24	0.37	0.37
liver, adult, pool1	10018-101C9	34.36	21.07	4.54	0.32	0.32	0.81	0.32	0.16
liver, fetal, pool1	10086-102B5	13.17	7.53	2.82	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	65.04	36.60	11.37	0.87	0.15	0.29	0.58	0.44
locus coeruleus, adult, donor10252	10165-103B3	98.00	43.37	14.21	1.48	0.18	0.00	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	33.01	24.26	9.31	1.41	1.13	0.28	0.28	1.97
locus coeruleus, newborn, donor10223	10362-105F2	42.90	16.40	6.31	0.84	0.00	0.00	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	19.79	16.05	1.94	0.14	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	60.67	46.88	11.03	2.07	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	75.79	64.85	6.46	0.13	0.53	0.79	0.13	0.40
lung, adult, pool1	10019-101D1	43.23	18.66	11.93	0.95	0.71	0.71	0.00	0.47
lung, fetal, donor1	10068-101I5	80.20	47.95	25.12	3.42	0.57	0.57	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	31.16	21.54	11.46	0.00	0.92	2.29	0.46	0.92
lymph node, adult, donor1	10077-102A5	35.98	22.25	9.47	1.42	0.47	1.89	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	56.99	18.63	12.93	0.00	0.22	0.22	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	91.31	28.83	18.41	0.60	0.30	0.00	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	123.18	62.86	17.84	0.85	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	45.73	12.88	12.43	0.44	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	39.43	13.07	10.79	0.62	0.21	0.00	0.00	0.00
mature adipocyte, donor3	12233-129G1	39.12	15.17	8.30	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	42.90	19.48	5.79	0.79	0.00	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	78.39	65.52	15.49	0.71	0.00	0.95	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	91.37	29.33	15.79	2.26	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	114.39	53.88	23.54	1.84	0.37	0.74	0.55	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	54.01	29.23	10.17	1.59	0.32	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	30.71	18.77	3.41	0.43	0.85	0.00	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	84.38	49.95	16.37	2.36	0.68	0.84	1.69	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	122.24	59.64	20.80	0.85	0.64	0.21	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	34.67	13.48	3.85	1.93	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	0.00	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	44.51	23.33	7.54	0.00	0.72	0.00	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	51.27	29.20	11.68	0.65	0.65	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	97.06	42.11	17.03	0.46	0.46	0.31	0.15	0.31
medulla oblongata, adult, pool1	10038-101F2	84.65	53.22	19.35	0.73	0.41	0.16	0.33	0.24
medulla oblongata, newborn, donor10223	10361-105F1	44.79	19.09	8.33	0.00	0.69	0.00	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	226.73	133.29	12.84	0.22	1.77	1.55	0.89	1.77
medulloblastoma cell line:ONS-76	10759-110E3	91.34	55.88	8.07	0.12	0.00	0.49	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	65.98	23.72	9.06	0.14	0.57	1.29	0.14	0.57
melanoma cell line:G-361	10465-106H6	43.71	33.66	2.99	0.54	0.81	1.36	1.36	1.36
meningioma cell line:HKBMM	10691-109F7	35.28	24.06	4.52	0.00	0.72	0.18	1.27	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	141.87	120.72	18.50	0.88	1.76	1.76	5.29	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	150.87	80.10	14.78	0.52	0.78	0.26	0.52	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	46.95	24.86	5.22	0.00	0.00	0.00	0.77	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	39.99	22.00	5.09	0.00	0.00	0.18	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	33.96	16.15	3.73	0.00	0.41	0.00	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	41.44	20.51	4.78	0.14	0.00	0.00	0.00	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	40.44	13.29	3.85	0.00	0.19	0.19	0.39	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	45.81	12.49	4.86	0.00	0.00	0.69	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	36.04	14.76	5.15	0.00	0.00	0.00	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	44.51	20.47	5.52	0.00	0.23	0.35	1.15	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	48.55	21.75	3.71	0.00	0.40	0.13	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	45.24	17.02	7.43	0.00	0.27	0.14	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	62.31	20.06	4.98	0.14	0.28	0.43	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	31.29	10.87	6.26	0.00	0.66	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	50.64	22.42	6.37	0.00	0.28	0.14	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	58.30	16.76	5.59	0.00	0.35	0.70	0.00	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	30.22	12.66	3.27	0.00	0.20	0.00	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	37.74	15.82	3.95	0.00	0.00	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	38.07	17.79	3.41	0.00	0.31	0.10	0.10	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	41.27	7.98	3.42	0.23	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	36.92	17.20	4.62	0.42	0.42	0.84	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	43.64	14.94	3.74	0.00	0.15	0.30	0.30	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	42.89	15.84	2.71	0.00	0.18	0.18	0.09	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	46.76	16.94	2.21	0.00	0.37	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	48.93	13.16	5.15	0.00	0.86	0.00	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	62.31	23.16	6.74	0.00	0.84	0.00	0.42	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	30.60	10.50	7.76	0.00	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	33.76	13.81	3.07	0.00	0.26	0.51	0.00	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.38	14.40	7.59	0.26	1.05	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	31.42	16.33	5.85	0.00	0.00	0.31	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.30	11.77	5.41	0.24	0.24	0.00	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.91	13.54	6.09	0.00	0.00	0.68	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.90	10.61	2.36	0.00	0.39	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.27	9.73	3.71	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	49.32	15.29	6.92	0.29	0.58	0.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	34.36	13.61	6.02	0.00	0.89	0.45	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	32.69	9.37	8.17	0.48	0.72	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	57.20	22.73	11.73	0.00	0.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.17	12.08	5.71	0.00	0.34	0.67	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	26.20	12.28	4.91	0.00	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.36	10.31	5.15	0.00	0.00	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	13.67	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	5.16	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.93	10.39	6.17	0.00	0.32	0.00	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	26.19	4.36	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	29.85	12.79	4.26	0.00	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	25.35	8.18	4.09	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	25.66	8.94	5.44	0.00	0.39	0.00	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	4.20	4.20	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	27.82	3.97	2.98	0.00	0.00	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	38.14	0.00	9.53	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	28.46	10.08	3.56	0.00	0.00	0.59	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	6.09	6.09	0.00	0.00	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	20.27	8.87	4.43	0.00	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	19.31	3.10	5.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	8.60	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	3.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	3.44	0.00	3.44	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.56	3.67	4.48	0.00	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	10.33	3.18	0.00	0.00	0.00	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	3.54	1.77	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.77	3.74	2.81	0.00	0.31	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	5.35	5.35	0.00	1.34	0.00	0.00	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	36.66	8.28	4.73	0.00	1.18	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	15.41	2.57	0.00	2.57	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	45.43	8.95	6.88	0.69	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	50.97	11.38	3.46	0.49	0.49	0.49	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	7.85	7.85	0.00	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	38.16	12.72	1.27	0.00	0.00	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	33.45	9.27	3.22	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	47.97	13.08	4.36	2.18	0.00	2.18	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	31.68	3.80	7.60	0.00	0.00	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	17.60	8.50	3.03	0.00	0.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	0.00	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	4.94	1.65	0.00	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	16.07	4.76	3.17	0.60	0.20	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.66	5.19	4.87	0.65	0.65	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	25.47	5.09	5.09	0.00	2.04	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	67.31	46.42	13.15	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	79.38	46.54	8.27	0.00	0.00	0.24	0.24	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	89.43	36.14	7.65	0.00	0.46	0.00	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	0.00	4.27	0.00	4.27	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.24	19.32	2.77	0.10	0.31	0.21	0.51	0.82
mesothelioma cell line:Mero-25	10850-111F4	94.41	41.76	7.49	0.00	0.91	0.91	0.91	0.45
mesothelioma cell line:Mero-41	10851-111F5	78.23	32.52	11.73	0.00	0.24	0.00	0.00	1.22
mesothelioma cell line:Mero-48a	10852-111F6	52.92	17.05	6.20	0.22	0.00	0.44	0.44	0.66
mesothelioma cell line:Mero-82	10853-111F7	93.56	40.47	4.47	0.26	1.84	0.26	0.26	1.05
mesothelioma cell line:Mero-83	10854-111F8	89.03	27.75	5.11	0.00	1.02	0.68	0.34	0.51
mesothelioma cell line:Mero-84	10855-111F9	70.78	25.53	2.27	0.00	1.26	0.25	1.01	0.51
mesothelioma cell line:Mero-95	10856-111G1	45.96	13.66	5.38	0.00	0.21	0.00	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	38.43	11.26	3.48	0.00	0.17	0.33	0.33	0.33
mesothelioma cell line:NCI-H226	10846-111E9	63.35	19.00	4.89	0.00	0.36	0.54	0.54	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	51.08	25.96	7.00	0.00	0.00	0.34	0.68	0.85
mesothelioma cell line:NCI-H28	10845-111E8	52.17	31.81	3.82	0.00	0.51	0.00	0.76	1.02
mesothelioma cell line:No36	10857-111G2	58.39	16.96	3.59	0.00	0.65	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	82.91	29.26	5.96	0.00	0.81	0.54	0.54	0.81
migratory langerhans cells, donor1	11901-125F2	39.54	12.47	10.17	1.34	0.00	0.19	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	52.14	20.39	13.92	0.85	0.12	0.24	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	34.64	15.44	9.87	0.54	0.36	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	93.05	37.55	10.45	0.33	1.63	2.29	1.63	5.22
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	41.33	26.70	2.97	0.00	1.27	0.00	0.21	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	116.33	94.68	10.83	0.00	0.23	0.23	0.23	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	42.44	27.78	4.95	0.19	0.00	0.57	0.00	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	136.01	53.04	24.21	0.55	0.55	0.37	0.00	0.74
myeloma cell line:PCM6	10474-106I6	62.46	32.42	17.00	0.20	0.20	0.20	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	103.99	56.31	4.57	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	56.68	20.40	8.43	0.00	0.00	0.00	0.00	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.08	12.37	13.26	0.67	0.11	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	28.39	11.91	8.31	0.44	0.00	0.00	0.15	0.44
nasal epithelial cells, donor2	12227-129F4	183.26	29.81	22.08	0.55	0.00	0.00	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	101.00	155.52	10.12	1.38	1.15	0.46	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	164.07	98.97	25.44	0.56	0.56	0.94	0.37	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	171.66	82.04	8.01	0.00	0.84	0.84	1.05	0.63
neuroblastoma cell line:NH-12	10555-107I6	173.31	126.35	10.44	0.00	0.93	0.37	0.37	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	88.72	47.21	10.91	0.24	0.71	0.24	0.71	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	88.22	51.95	10.77	0.00	1.11	0.48	0.63	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	81.31	32.60	11.27	0.20	0.40	0.40	0.20	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	155.76	63.58	11.44	0.00	0.00	0.00	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	51.90	19.16	2.93	0.00	0.27	0.53	0.00	0.80
neutrophil PMN, donor1	12133-128D9	104.12	29.75	89.25	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	13.28	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	0.00	37.88	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	206.67	116.69	19.11	0.51	1.01	0.34	1.01	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	63.24	39.22	1.60	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.55	17.63	3.85	0.00	0.00	0.00	0.64	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	40.20	18.39	3.94	0.00	0.53	0.26	0.26	1.05
nucleus accumbens, adult, pool1	10037-101F1	115.49	67.96	28.50	1.50	0.37	0.37	0.19	0.75
occipital cortex - adult, donor10196	10172-103C1	92.72	41.21	8.24	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	134.72	65.21	26.30	0.54	1.07	0.27	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	60.41	30.57	11.65	0.36	0.00	0.36	0.73	0.73
occipital lobe, adult, donor1	10076-102A4	89.48	53.79	17.06	1.05	2.10	0.79	0.26	0.52
occipital lobe, fetal, donor1	10073-102A1	109.42	73.81	20.60	2.15	1.72	0.86	0.86	1.29
occipital pole, adult, pool1	10036-101E9	106.99	67.72	28.07	1.18	0.47	0.39	0.08	0.39
olfactory region, adult	10195-103E6	90.18	54.26	17.58	1.34	0.96	0.00	0.38	0.96
optic nerve, donor1	10277-104E7	58.03	64.03	18.01	6.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	51.26	24.49	7.86	0.23	0.11	0.23	0.46	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	62.92	38.61	4.53	0.00	0.27	0.14	0.00	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	74.84	29.46	9.99	0.00	0.51	0.17	1.02	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	68.73	36.96	4.50	0.00	0.58	0.35	0.46	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	51.15	30.28	4.70	0.29	0.29	0.00	0.59	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	262.55	174.72	23.36	1.87	0.00	0.00	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	145.26	57.47	10.82	1.06	0.85	0.64	0.64	1.06
ovary, adult, pool1	10020-101D2	78.53	53.55	11.79	1.22	1.22	1.75	0.26	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	65.26	25.85	7.52	0.18	0.00	0.37	0.55	0.55
pancreas, adult, donor1	10049-101G4	29.16	26.34	18.81	0.94	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	53.67	29.07	7.83	0.00	0.56	0.56	0.00	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	48.55	28.11	8.69	0.00	0.34	0.17	0.17	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	51.66	39.41	7.62	1.82	0.17	0.00	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	102.14	58.39	26.45	0.73	0.18	0.27	0.55	0.18
parietal cortex, adult, donor10258	10373-105G4	111.57	30.83	17.62	0.00	0.00	0.00	0.00	2.20
parietal lobe - adult, donor10196	10171-103B9	85.58	29.15	12.23	3.76	0.00	0.94	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	110.02	50.17	17.39	1.71	0.29	0.29	1.71	1.71
parietal lobe, adult, pool1	10034-101E7	112.18	63.36	26.08	1.67	0.44	0.35	0.18	0.18
parietal lobe, fetal, donor1	10072-101I9	92.13	75.65	14.55	1.94	0.97	0.00	3.88	0.97
parietal lobe, newborn, donor10223	10356-105E5	50.10	17.57	7.85	0.37	0.37	0.00	0.37	2.24
parotid gland, adult	10199-103F1	38.23	22.20	8.02	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	42.43	25.24	16.65	1.61	1.61	1.07	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	122.90	60.43	12.83	0.37	0.19	1.30	0.56	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	62.07	38.32	6.12	0.00	0.29	0.58	0.29	0.15
pineal gland - adult, donor10196	10179-103C8	126.43	74.82	12.26	0.65	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	165.82	95.35	24.28	5.33	0.00	0.00	0.59	1.78
pineal gland, adult, donor10258	10377-105G8	92.18	46.40	8.15	0.00	1.88	1.25	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	90.05	46.54	19.22	2.02	0.00	0.00	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	149.58	65.15	23.45	3.65	1.04	1.56	1.04	0.52
pituitary gland, adult, donor10258	10378-105G9	67.25	23.83	4.26	0.85	0.85	0.85	0.00	0.00
placenta, adult, pool1	10021-101D3	32.57	16.66	17.20	0.75	0.43	0.54	0.00	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	96.41	32.18	12.85	0.40	1.19	0.40	0.53	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	73.31	50.58	12.30	0.47	0.16	0.00	0.16	0.31
pons, adult, pool1	10033-101E6	76.43	46.82	13.17	0.34	0.43	0.17	0.09	0.43
postcentral gyrus, adult, pool1	10032-101E5	113.76	65.21	25.89	1.66	0.78	0.17	0.52	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	242.60	138.03	33.46	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	22.03	5.51	0.00	0.00	0.00	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	82.74	36.42	6.12	0.73	0.44	0.29	0.44	1.31
prostate cancer cell line:PC-3	10439-106E7	108.90	40.29	11.07	0.36	0.18	0.00	0.54	0.36
prostate, adult, pool1	10022-101D4	58.22	33.74	13.15	1.72	0.27	0.82	0.09	0.18
putamen, adult, donor10196	10176-103C5	114.02	52.88	24.79	2.12	0.47	0.47	0.94	0.47
putamen, adult, donor10252	10152-102I8	64.70	27.45	11.76	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	66.66	13.11	5.46	0.00	0.00	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	64.99	32.38	17.88	0.24	0.24	0.00	0.00	0.72
putamen, newborn, donor10223	10365-105F5	35.23	9.00	3.75	0.75	1.50	0.75	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	109.39	46.84	8.44	0.58	0.00	0.29	0.00	0.58
rectum, fetal, donor1	10067-101I4	55.64	45.90	11.13	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	21.20	13.99	4.45	0.00	0.00	0.00	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	26.10	8.28	4.14	1.24	0.00	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	73.56	55.27	22.36	1.89	0.40	0.40	0.60	0.20
retinoblastoma cell line:Y79	10475-106I7	159.26	109.64	16.37	1.56	0.78	0.26	1.04	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	109.55	57.91	7.38	0.25	0.12	0.49	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	248.30	153.25	23.06	0.84	1.12	1.12	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	73.51	37.89	6.82	0.00	0.00	0.76	1.52	0.00
salivary acinar cells, donor1	11771-123I7	41.44	23.47	3.40	0.00	0.16	0.81	0.16	0.32
salivary acinar cells, donor2	11772-123I8	38.69	17.07	5.09	0.00	0.41	0.14	0.14	0.28
salivary acinar cells, donor3	11773-123I9	62.89	29.13	9.27	0.00	0.00	0.66	0.66	0.66
salivary gland, adult, pool1	10093-102C3	40.04	15.44	12.01	2.29	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.25	33.47	4.22	0.17	0.25	0.17	0.34	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	40.20	34.21	6.82	0.47	0.00	0.35	0.12	0.24
seminal vesicle, adult	10201-103F3	75.66	37.03	19.05	0.53	0.53	0.53	0.53	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	55.14	19.19	11.17	0.00	0.24	0.00	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	47.56	15.10	5.03	0.25	0.50	0.75	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	50.18	12.04	8.03	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	63.40	20.82	6.45	0.13	0.13	0.54	0.27	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	45.32	49.85	4.31	0.11	0.44	0.55	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	34.84	29.16	4.52	0.26	0.00	0.13	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	48.23	26.95	13.48	0.71	0.71	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	39.70	21.35	16.55	0.72	1.20	0.60	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	33.17	49.25	18.09	2.01	2.01	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	13.57	13.57	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	57.44	26.51	15.78	0.63	1.89	3.16	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	99.72	71.37	8.67	0.00	0.33	0.33	0.33	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	131.13	91.41	8.51	2.52	1.58	0.63	2.21	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	245.37	94.25	19.66	0.39	0.96	0.39	1.16	2.51
small cell lung carcinoma cell line:LK-2	10541-107H1	79.12	69.72	7.58	0.33	0.16	0.16	0.82	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	147.82	43.27	16.41	0.00	0.80	0.16	0.48	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	105.25	75.40	7.85	0.22	0.87	0.44	0.22	0.87
small intestine, adult, pool1	10024-101D6	44.07	25.08	14.93	0.96	0.12	0.60	0.00	0.36
small intestine, fetal, donor1	10064-101I1	33.41	25.31	7.62	0.25	0.25	0.25	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	42.57	40.01	5.64	1.03	0.00	0.00	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	44.97	31.01	12.41	1.03	0.26	0.26	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	90.59	76.92	7.24	0.27	1.07	0.00	0.00	0.54
spinal cord - adult, donor10196	10181-103D1	48.63	41.98	11.24	5.05	0.46	0.69	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	80.83	39.03	11.43	7.49	0.00	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	30.44	10.38	6.92	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	83.55	68.91	18.90	1.22	1.22	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	34.90	13.32	3.67	2.30	0.92	0.00	0.92	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	54.51	23.90	6.12	0.30	0.30	0.15	0.00	0.75
spleen, adult, pool1	10025-101D7	62.12	26.76	14.65	1.10	0.44	0.66	0.00	0.22
spleen, fetal, pool1	10044-101F8	79.85	32.74	22.41	0.40	0.32	0.16	0.32	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	53.52	19.05	8.59	0.31	0.21	0.10	0.21	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	65.32	55.25	5.89	0.38	0.00	0.19	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	99.24	34.25	17.47	0.00	1.40	0.35	0.35	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	99.69	30.10	15.25	0.00	0.39	0.78	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	56.17	32.19	11.03	0.23	0.23	0.00	0.00	1.01
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	72.01	44.90	3.81	0.42	0.00	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	115.50	69.81	10.15	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	49.13	59.81	10.68	3.20	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	39.88	21.65	10.82	0.00	1.71	0.00	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	54.27	54.27	0.00	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	87.65	38.22	15.58	1.25	0.21	0.21	0.62	1.04
substantia nigra, adult, donor10258	10371-105G2	48.62	16.55	9.31	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	33.92	11.31	3.53	0.71	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	103.86	60.53	14.44	0.46	0.46	0.23	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	121.65	71.80	29.42	1.61	0.85	0.25	0.42	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	133.91	89.03	35.61	2.85	2.85	0.00	2.85	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	133.18	72.96	21.10	0.88	0.44	0.88	0.88	0.88
tenocyte, donor1	11763-123H8	65.98	25.83	10.82	0.00	0.70	0.00	0.70	1.75
tenocyte, donor2	11765-123I1	31.28	10.30	6.49	0.00	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	46.33	10.75	7.04	0.00	0.37	0.00	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	134.27	39.26	10.20	0.00	0.17	0.34	0.68	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	92.33	44.55	4.78	0.46	0.46	1.23	0.15	1.39
teratocarcinoma cell line:PA-1	10807-111A6	119.02	53.93	10.54	0.15	0.15	0.15	0.15	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	160.59	58.52	21.45	0.13	0.63	2.03	1.14	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	125.93	56.73	22.69	0.00	0.00	0.38	0.38	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	143.53	79.40	28.68	0.65	0.44	0.76	0.87	0.76
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.98	38.76	29.64	0.00	0.98	0.98	0.98	0.98
testis, adult, pool1	10026-101D8	153.65	94.49	45.63	10.20	9.88	8.48	2.15	0.97
testis, adult, pool2	10096-102C6	285.54	196.22	65.86	2.26	2.26	3.16	2.26	4.06
thalamus - adult, donor10196	10168-103B6	81.69	48.58	14.35	2.21	0.00	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	102.52	53.76	17.35	1.72	0.78	0.16	0.16	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	52.35	18.48	4.62	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.16	20.59	5.93	0.82	0.33	0.00	0.00	1.15
thalamus, newborn, donor10223	10366-105F6	30.49	6.90	2.30	0.58	0.00	0.58	0.00	1.15
throat, adult	10209-103G2	47.94	23.22	13.48	0.00	0.50	0.00	0.50	0.75
throat, fetal, donor1	10061-101H7	51.19	34.43	13.71	0.30	0.30	0.30	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	142.09	64.59	8.94	0.00	0.99	0.60	0.60	0.99
thymus, adult, pool1	10027-101D9	136.30	56.87	28.43	1.19	1.49	3.38	0.80	0.89
thymus, fetal, pool1	10043-101F7	137.88	52.99	21.82	0.42	0.62	1.25	0.52	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	62.23	21.81	9.17	0.13	0.40	0.00	0.27	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	65.93	37.30	17.88	0.28	0.28	0.14	0.14	0.98
thyroid, adult, pool1	10028-101E1	55.61	33.41	16.70	0.84	0.75	0.56	0.28	0.65
thyroid, fetal, donor1	10060-101H6	42.71	30.85	13.18	0.26	0.26	0.53	0.53	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	30.80	9.24	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	37.44	25.12	11.16	0.47	0.93	1.40	0.23	1.16
tongue, fetal, donor1	10059-101H5	47.69	24.83	7.09	0.00	0.39	0.39	0.79	0.00
tonsil, adult, pool1	10047-101G2	84.15	32.46	21.54	1.00	0.30	0.30	0.20	0.20
trachea, adult, pool1	10029-101E2	47.44	26.50	14.07	0.49	0.49	0.82	0.41	0.08
trachea, fetal, donor1	10058-101H4	36.93	27.31	11.93	1.15	0.77	0.38	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	54.20	25.15	3.54	0.00	0.35	0.35	0.00	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	56.13	35.06	5.67	0.51	0.51	0.41	0.00	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	95.58	52.02	17.86	0.16	1.25	1.25	0.63	1.41
tridermal teratoma cell line:HGRT	10694-109G1	100.83	34.25	3.81	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	51.38	40.46	7.03	0.17	0.17	0.17	0.25	0.34
umbilical cord, fetal, donor1	10057-101H3	50.08	25.04	14.61	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	61.94	45.22	19.45	3.75	0.34	1.02	0.17	0.17
uterus, fetal, donor1	10055-101H1	54.26	32.25	16.89	0.51	1.02	1.02	1.54	0.51
vagina, adult	10204-103F6	60.10	24.56	8.40	0.65	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	62.91	28.06	12.49	0.22	0.44	1.10	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	63.29	18.69	8.28	0.53	0.53	0.27	0.00	0.53